hopTo (HPTO) 10-K 30 Mar 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 24, 2016	Jun. 30, 2015
Document And Entity Information
Entity Registrant Name	hopTo Inc.
Entity Central Index Key	1,021,435
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 10,998,045
Entity Common Stock, Shares Outstanding		9,861,078
Trading Symbol	HPTO
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Assets:
Cash	$ 1,777,300	$ 1,557,100
Accounts receivable, net of allowance for doubtful accounts of $17,300 and $32,600, respectively	434,900	2,211,300
Prepaid expenses and other current assets	139,200	98,100
Total Current Assets	2,351,400	3,866,500
Capitalized software development costs, net	20,800	408,700
Property and equipment, net	252,500	362,500
Other assets	109,000	139,700
Total Assets	2,733,700	4,777,400
Current Liabilities:
Accounts payable	385,200	204,600
Accrued expenses	69,600	116,200
Accrued wages	557,300	665,700
Severance liability	5,900	0
Deferred rent	21,000	44,500
Capital lease	8,400	7,700
Deferred revenue	2,467,000	2,859,300
Total Current Liabilities	3,514,400	3,898,000
Long Term Liabilities:
Warrants liability	31,600	647,300
Deferred revenue	1,465,800	$ 1,652,600
Deposit liability	81,400
Capital lease	6,800	$ 15,200
Deferred rent	26,700	158,200
Total Liabilities	$ 5,126,700	$ 6,371,300
Shareholders’ Equity (Deficit):
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.0001 par value, 195,000,000 shares authorized, 9,731,233 and 7,502,815 shares issued and outstanding, respectively	$ 14,600	$ 11,200
Additional paid-in capital	78,189,300	74,600,700
Accumulated deficit	(80,596,900)	(76,205,800)
Total Shareholders’ Deficit	(2,393,000)	(1,593,900)
Total Liabilities and Shareholders’ Deficit	$ 2,733,700	$ 4,777,400

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 17,300	$ 32,600
Preferred stock par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	195,000,000	195,000,000
Common stock, shares issued	9,731,233	7,502,815
Common stock, shares outstanding	9,731,233	7,502,815

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue
Software licenses	$ 2,330,000	$ 2,725,100
Software service fees	2,605,900	2,708,300
Other	45,100	120,000
Total Revenue	4,981,000	5,553,400
Cost of revenue
Software service costs	169,500	203,200
Software product costs	257,500	$ 250,200
Write-down of capitalized software development costs	182,400
Total Cost of Revenue	609,400	$ 453,400
Gross Profit	4,371,600	5,100,000
Operating Expenses
Selling and marketing	1,588,200	2,069,700
General and administrative	3,136,600	3,333,800
Research and development	4,224,000	4,911,400
Total Operating Expenses	8,948,800	10,314,900
Loss from Operations	(4,577,200)	(5,214,900)
Other Income (Expense)
Change in fair value of warrants liability	190,300	1,624,300
Interest and other income	1,400	1,100
Interest and other expense	(1,900)	(1,300)
Total other income (expense)	189,800	1,624,100
Loss from operations before provision for income tax	(4,387,400)	(3,590,800)
Provision for income tax	3,700	3,100
Net loss	$ (4,391,100)	$ (3,593,900)
Loss per share – basic and diluted	$ (0.52)	$ (0.48)
Weighted Average Common Shares Outstanding – Basic and Diluted	8,437,390	7,440,173

Consolidated Statements of Shar

Consolidated Statements of Shareholders’ Equity (Deficit) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2013		$ 9,800	$ 71,697,300	$ (72,611,900)	$ (1,593,900)
Beginning balance, shares at Dec. 31, 2013		6,567,375
Private placement of stock and warrants		$ 1,200
Private placement of stock and warrants, shares		753,333
Employee stock option issuances
Employee stock option issuances, shares		17,121
Exercise of warrants		$ 100
Exercise of warrants, shares		66,667			66,667
Vesting of restricted stock awards		$ 100
Vesting of restricted stock awards, shares		98,319
Stock-based compensation expense			$ 593,000
Company payment of employee taxes for stock-based compensation			(6,400)
Proceeds from exercise of employee stock options			47,800
Proceeds from exercise of warrants			259,800
Proceeds from private placement of common stock and warrants, net of par value of shares issued			3,388,800
Cost of private placement of common stock and warrants			(20,000)
Allocation of proceeds from common stock and warrants to warrants liability			(1,356,000)
Accretion of compensation expense, net of forfeitures - consultant warrants			$ (3,600)
Reclassification of warrants liability to equity (2014 PIPE)
Other Rounding			$ (100)
Net loss				$ (3,593,900)	$ (3,593,900)
Ending balance at Dec. 31, 2014		$ 11,200	$ 74,600,700	$ (76,205,800)	$ (1,593,900)
Ending balance, shares at Dec. 31, 2014		7,502,814
Private placement of stock and warrants		$ 3,200
Private placement of stock and warrants, shares		2,105,919
Employee stock option issuances
Employee stock option issuances, shares		6,000
Exercise of warrants
Exercise of warrants, shares
Vesting of restricted stock awards		$ 200
Vesting of restricted stock awards, shares		116,500
Stock-based compensation expense			$ 757,500
Company payment of employee taxes for stock-based compensation			(11,900)
Proceeds from exercise of employee stock options			$ 4,900
Proceeds from exercise of warrants					$ 2,014,000
Proceeds from private placement of common stock and warrants, net of par value of shares issued			$ 2,547,300
Cost of private placement of common stock and warrants			$ (116,400)
Allocation of proceeds from common stock and warrants to warrants liability
Accretion of compensation expense, net of forfeitures - consultant warrants
Reclassification of warrants liability to equity (2014 PIPE)			$ 407,300
Other Rounding			(100)
Net loss				$ (4,391,100)	$ (4,391,100)
Ending balance at Dec. 31, 2015		$ 14,600	$ 78,189,300	$ (80,596,900)	$ (2,393,000)
Ending balance, shares at Dec. 31, 2015		9,731,233

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash Flows Provided By (Used In) Operating Activities:
Net loss	$ (4,391,100)	$ (3,593,900)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	334,800	$ 385,000
Write-down of capitalized software development costs	182,400
Stock based compensation expense	757,500	$ 593,000
Company payments of employee taxes for stock-based compensation	(11,900)	(6,400)
Revenue deferred to future periods	3,114,200	5,421,800
Recognition of deferred revenue	(3,693,300)	(4,159,000)
Change in allowance for doubtful accounts	(15,300)	(9,400)
Change in fair value of derivative instruments - warrants	(190,300)	(1,624,300)
Accretion of warrants liability for consulting services	$ (18,100)	(64,200)
Accretion of equity warrants for consulting services		$ (3,600)
Interest accrued for capital lease	$ 1,700
Changes in severance liability	5,900	$ (62,900)
Changes in deferred rent	(155,000)	(19,700)
Changes in operating assets and liabilities:
Accounts receivable	1,791,700	(1,390,200)
Prepaid expenses and other current assets	(300)	(46,600)
Other long term assets	(10,000)	200
Accounts payable	150,600	(101,000)
Accrued expenses	(46,600)	78,800
Accrued wages	(108,400)	$ 103,600
Deposit Liability	81,400
Net Cash Used In Operating Activities	(2,220,100)	$ (4,498,800)
Cash Flows Used In Investing Activities:
Capitalized software development costs	(12,000)
Capital expenditures	(7,300)	$ (50,600)
Net Cash Used In Investing Activities	(19,300)	(50,600)
Cash Flows Provided By (Used In) Financing Activities:
Proceeds from exercise of employee stock options	$ 4,900	47,800
Proceeds from exercise of warrants		260,000
Proceeds from private placement of common stock and warrants	$ 2,550,500	3,390,000
Cost associated with private placement of common stock and warrants	(86,400)	(20,000)
Payments for capital lease	(9,400)	(2,000)
Net Cash Provided By Financing Activities	2,459,600	3,675,800
Net Decrease in Cash	220,200	(873,600)
Cash, beginning of year	1,557,100	2,430,700
Cash, end of year	$ 1,777,300	$ 1,557,100

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. Basis of Presentation The Company hopTo Inc., and its subsidiaries (the “Company”) is a developer of software productivity products for mobile devices such as tablets and smartphones, and application publishing software solutions. Its newest product line, which is called hopTo, was originally marketed to consumers and is now also marketed to small and medium sized businesses and enterprise level customers under the name hopTo Work. hopTo provides mobile end-users with a productivity workspace for their mobile devices that allows users to manage, share, view, and edit their documents, regardless of where they are stored. The Company launched the first public release of hopTo through Apple’s App Store on April 15, 2013. This release was targeted at Apple’s tablet devices, the iPad and the iPad Mini. The Company also launched the first commercial version of hopTo through Apple’s App Store on November 14, 2013. On November 10, 2014, we launched the first version of hopTo Work, a version of the hopTo workspace made available to businesses for a fee. hopTo Work expands upon the core capabilities of hopTo by providing mobile access to applications that businesses rely on for their daily operations. Future releases will be targeted at other devices such as Apple’s iPhone, as well as competing devices such as those based on Google’s Android platform. In addition to hopTo, the Company also sells a family of products under the brand name GO-Global, which is a software application publishing business and is the Company’s sole revenue source at this time. GO-Global is an application access solution for use and/or resale by independent software vendors (“ISVs”), corporate enterprises, governmental and educational institutions, and others, who wish to take advantage of cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are deploying secure, private cloud environments. Over the years, the Company has also made significant investments in intellectual property (“IP”). It has filed many patents designed to protect the new technologies embedded in hopTo. The Company plans to continue to aggressively invest in the creation and protection of new IP as it continues to develop hopTo, hopTo Work, and other products. The Company’s operations have historically been conducted and reported in two segments, GO-Global and hopTo, each representing a specific product line. On January 27, 2016, we filed an amendment of our Amended and Restated Certificate of Incorporation, as amended, to effect a 1-for-15 reverse stock split of our common stock (the “Reverse Stock Split”). The Reverse Stock Split became effective in the stock market upon commencement of trading on January 28, 2016. As a result of the Reverse Stock Split, every fifteen shares of our pre-Reverse Stock Split common stock were combined and reclassified into one share of our common stock. No fractional shares were issued in connection with the Reverse Stock Split, and cash paid to stockholders for potential fractional shares was insignificant. The number of shares of common stock subject to outstanding options, restricted stock units, warrants and convertible securities were also reduced by a factor of fifteen as of January 27, 2016. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the Reverse Stock Split. The authorized number of shares and the par value per share of our common stock were not affected by the Reverse Stock Split.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Basis of Presentation and Use of Estimates Cash Equivalents Property and Equipment Shipping and Handling Software Development Costs “Costs of Software to be Sold, Leased or Marketed,” Revenue Recognition Software license revenues are recognized when: ● Persuasive evidence of an arrangement exists (i.e., when the Company signs a non-cancelable license agreement wherein the customer acknowledges an unconditional obligation to pay, or upon receipt of the customer’s purchase order) and ● Delivery has occurred or services have been rendered and there are no uncertainties surrounding product acceptance (i.e., when title and risk of loss have been transferred to the customer, which generally occurs when the media containing the licensed program(s) is provided to a common carrier or, in the case of electronic delivery, when the customer is given access to the licensed programs), and ● The price to the customer is fixed or determinable, as typically evidenced in a signed non-cancelable contract, or a customer’s purchase order, and ● Collectability is probable. If collectability is not considered probable, revenue is recognized when the fee is collected. Revenue recognized on software arrangements involving multiple deliverables is allocated to each deliverable based on vendor-specific objective evidence (“VSOE”) or third party evidence of the fair values of each deliverable; such deliverables include licenses for software products, maintenance, private labeling fees, or customer training. The Company limits its assessment of VSOE for each deliverable to either the price charged when the same deliverable is sold separately or the price established by management having the relevant authority to do so, for a deliverable not yet sold separately. If sufficient VSOE of fair value does not exist, so as to permit the allocation of revenue to the various elements of the arrangement, all revenue from the arrangement is deferred until such evidence exists or until all elements are delivered. If VSOE of the fair value does not exist and the only undelivered element is maintenance, then we recognize revenue on a ratable basis. If VSOE of the fair value of all undelivered elements exists but evidence does not exist for one or more delivered elements, then revenue is recognized using the residual method. Under the residual method, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is recognized as revenue. Certain resellers (“stocking resellers”) purchase product licenses that they hold in inventory until they are resold to the ultimate end-user (an “inventory stocking order”). At the time that a stocking reseller places an inventory stocking order, no product licenses are shipped by the Company to the stocking reseller rather, the stocking reseller’s inventory is credited with the number of licenses purchased and the stocking reseller can resell (issue) any number of licenses from their inventory at any time. Upon receipt of an order to issue one or more licenses from a stocking reseller’s inventory (a “draw down order”), the Company will ship the licenses(s) in accordance with the draw down order’s instructions. The Company defers recognition of revenue from inventory stocking orders until the underlying licenses are sold and shipped to the end user, as evidenced by the receipt and fulfillment of the stocking reseller’s draw down order, assuming all other revenue recognition criteria have been met. There are no rights of return granted to purchasers of the Company’s software products. Revenue is recognized from maintenance contracts ratably over the related contract period, which generally ranges from one to five years. All of the Company’s software licenses are denominated in U.S. dollars. Deferred Rent Incentives received upon entering into the lease agreement are recognized on a straight-line basis as a reduction to rent over the term of the lease. The unamortized portion of these incentives are recorded as a part of deferred rent in current or long-term liabilities, as appropriate. Post-employment Benefits (Severance Liability) Allowance for Doubtful Accounts Beginning Balance Charge Offs Recoveries Provision Ending Balance 2015 $ 32,600 $ — $ — $ (15,300 ) $ 17,300 2014 $ 42,000 $ — $ — $ (9,400 ) $ 32,600 Income Taxes “Income Taxes,” The Company and one or more of its subsidiaries are subject to United States federal income taxes, as well as income taxes of multiple state and foreign jurisdictions. The Company and its subsidiaries are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to 2011. There are no tax examinations currently underway for any of the Company’s or its subsidiaries’ tax returns for years subsequent to 2010. The Company’s policy for deducting interest and penalties is to treat interest as interest expense and penalties as taxes. The Company had not accrued any amount for the payment of interest or penalties related to any uncertain tax positions at either December 31, 2015 or 2014, as its review of such positions indicated that such potential positions were minimal. Under FASB ASC 740-10-05, “Income Taxes,” Fair Value of Financial Instruments The fair value of the Company’s warrants are determined in accordance with FASB ASC 820, “Fair Value Measurement,” ● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. ● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation. As of December 31, 2015 and 2014, all of the Company’s $31,600 and $647,300 Warrants Liability reported at fair value, respectively, were categorized as Level 3 inputs (see Note 8). Derivative Financial Instruments Long-Lived Assets Loss Contingencies Stock-Based Compensation Compensation – Stock Compensation. Valuation and Expense Information Under FASB ASC 718-10 The Company recorded stock-based compensation expense of $757,500 and $593,000 in the years ended December 31, 2015 and 2014, respectively. No expense was capitalized related to software development. As required by FASB ASC 718-10, the Company estimates forfeitures of employee stock-based awards and recognizes compensation cost only for those awards expected to vest. Forfeiture rates are estimated based on an analysis of historical experience and are adjusted to actual forfeiture experience as needed. During 2015, we awarded 15,000 shares of restricted common stock to employees. The valuation of the restricted common stock awards was based on the closing fair market value of our common stock on the grant date. For these awards, such fair market value ranged from $1.95 to $2.40 per share. During 2015, we granted 57,911 options to purchase common stock to our Chief Financial Officer at an exercisable price of $1.80 per share. This option grant was offered as an exchange for forfeiting 44,445 of unreleased stock award that was originally awarded in May 2014. For all options granted during 2015 and 2014, the Company set the exercise price equal to the closing fair market value of the Company’s common stock as of the date of grant. The following table illustrates the non-cash stock-based compensation expense recorded during the years ended December 31, 2015 and 2014 by income statement classification: 2015 2014 Cost of revenue $ 9,000 $ 6,500 Selling and marketing expense 148,700 73,000 General and administrative expense 499,500 437,800 Research and development expense 100,300 75,700 $ 757,500 $ 593,000 The Company estimated the fair value of each option grant made during the years ended December 31, 2015 and 2014 on the date of grant using a binomial model, with the assumptions set forth in the following table: 2015 2014 Estimated volatility 103% 96% - 126% Annualized forfeiture rate 0% 0% - 6.0% Expected option term (years) 10.00 0.03 - 10.00 Estimated exercise factor 15.0 1.5 - 15.0 Approximate risk-free interest rate 0.74% 0.03% - 1.06% Expected dividend yield — — The estimated annualized forfeiture rate was based on an analysis of historical data and considered the impact of events such as work force reductions we carried out in previous years. The expected term of our stock-based awards was based on historical award holder exercise patterns and considered the market performance of our common stock and other items. The estimated exercise factor was based on an analysis of historical data; historical exercise patterns; and a comparison of historical and current share prices. The approximate risk free interest rate was based on the implied yield available on U.S. Treasury issues with remaining terms equivalent to our expected term on our stock-based awards. The Company used the average historical volatility of its daily closing price for a period of time equal in length to the expected option term for the option being issued. The period of time over which historical volatility was measured ended on the last day of the quarterly reporting period during which the stock-based award was made. The Company does not anticipate paying dividends on its common stock for the foreseeable future. Earnings Per Share of Common Stock “Earnings Per Share,” Comprehensive Loss “Reporting Comprehensive Income,” Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) In November, 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes In August 2015, FASB issued ASU No. 2015-14 “ Revenue from Contracts with Customers (Topic 606)” – Deferral of the Effective Date In April 2015, FASB issued ASU No. 2015-05 “ Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” In August 2014, FASB issued Accounting Standards Update (“ASU”) No. 2014-15 “ Preparation of Financial Statements - Going Concern (Subtopic 205-40).” In June 2014, FASB issued ASU No. 2014-12 “Compensation – Stock Compensation (Topic 718)” In May 2014, FASB issued ASU No. 2014-09 “ Revenue from Contracts with Customers (Topic 606)” 1. Removes inconsistencies and weaknesses in revenue requirements. 2. Provides a more robust framework for addressing revenue issues. 3. Improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. 4. Provides more useful information to users of financial statements through improved disclosure requirements. 5. Simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within such annual period. Early adoption is not permitted. We are currently evaluating this ASU in order to determine whether or not its adoption will have a material impact on our results of operations, cash flows or financial position. In April 2014, FASB issued ASU No. 2014-08 “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)” “Presentation of Financial Statements – Discontinued Operations,”

Capitalized Software Developmen

Capitalized Software Development Costs	12 Months Ended
	Dec. 31, 2015
Research and Development [Abstract]
Capitalized Software Development Costs	3. Capitalized Software Development Costs Capitalized software development costs as of December 31, 2015 and 2014 consisted of the following: 2015 2014 Software development costs $ 518,800 $ 1,135,900 Accumulated amortization (498,000 ) (727,200 ) $ 20,800 $ 408,700 During 2015 and 2014, we capitalized $12,000 and $16,500, respectively, of software development costs associated with hopTo. Such costs were the cost of licenses to third party software used by hopTo. Amortization of capitalized software development costs is a component of costs of revenue. Capitalized software development costs amortization aggregated $217,500 and $227,200 during the years ended December 31, 2015 and 2014, respectively. During 2015, we determined that an impairment of $182,400 existed with certain capitalized software development costs associated with our hopTo consumer product and recognized that cost as part of cost of revenue.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	4. Property and Equipment Property and equipment as of December 31, 2015 and 2015 consisted of the following: 2015 2014 Equipment $ 313,700 $ 306,400 Furniture & fixture 233,900 233,900 Leasehold improvements 167,600 167,600 715,200 707,900 Less: accumulated depreciation and amortization 462,700 345,400 $ 252,500 $ 362,500 Aggregate property and equipment depreciation expense for the years ended December 31, 2015 and 2014 was $117,300 and $157,800, respectively. During 2015, we capitalized $7,300 cost of equipment. During 2015, we did not retire any assets. During 2014, we capitalized the following costs: equipment; $35,700, furniture; $14,900, and leasehold improvements; $167,600. During 2014, we retired the following asset costs related to assets that were no longer in service as of September 30, 2014: equipment; $972,900, furniture; $213,400, and leasehold improvements; $147,500. All of the assets retired were either fully depreciated or amortized at the time of their respective retirement.

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2015
Payables and Accruals [Abstract]
Accrued Expenses	5. Accrued Expenses Accrued expenses as of December 31, 2015 and 2014 consisted of the following: 2015 2014 Consulting services $ 40,200 $ 77,300 Franchise tax 3,200 3,200 Software and subscription fees 4,900 15,900 Other 21,300 19,800 $ 69,600 $ 116,200

Severance Liability

Severance Liability	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Severance Liability	6. Severance Liability In August of 2015 we agreed to provide a terminated employee a lump sum payment $15,000 and six months of medical coverage payments which will end March 2, 2016. As of December 31, 2015 $5,900 remained outstanding associated with this severance liability. In July of 2014 we agreed to provide a terminated employee a lump sum salary payment and 4 months of medical coverage payments which ended December 31, 2014. As of December 31, 2014 $0 remained outstanding associated with these severance liabilities. The following table summarizes the salary continuation and medical coverage payments during the period ended December 31, 2015. Compensation Medical Coverage Total Balance at December 31, 2014 $ — — $ — Separation agreement entered into in 2015 — 17,700 17,700 Accrued interest — — — Payments — (11,800 ) (11,800 ) Balance at December 31, 2015 $ — $ 5,900 $ 5,900 Compensation Medical Coverage Total Balance at December 31, 2013 $ 62,900 — $ 62,900 Separation agreement entered into in 2015 37,500 10,600 48,100 Accrued interest 1,700 — 1,700 Payments (102,100 ) (10,600 ) (112,700 ) Balance at December 31, 2014 $ — — $ —

Deferred Rent

Deferred Rent	12 Months Ended
	Dec. 31, 2015
Revenue
Deferred Rent	7. Deferred Rent We amended our office lease during 2013. On February 1, 2014, we moved our corporate offices to a different building within the same office complex owned and operated by our landlord on South Bascom Avenue in Campbell, California, where our corporate offices had been located prior to February 1, 2014. Since the new space is controlled by the same landlord, we considered the lease amendment to be a modification to our preexisting lease; accordingly, we are amortizing the remaining balance in deferred rent immediately prior to February 1, 2014 over the remaining term of the modified amended lease. Additionally, our landlord provided us with $106,600 of leasehold improvements on the new space that we are amortizing over the remaining term of the amended lease. All of the prior leasehold improvements that had not been previously amortized were accelerated and recognized in their entirety from the time of the amendment through January 2014, prior to the move. On August 11, 2015, we entered into a sublease agreement to sublease the entirety of the South Bascom office space to a third party. The term of the sublease extends through the end of our office lease term for that space and the monthly rent payments due to hopTo fully offset the monthly rent payments due to the landlord under hopTo’s lease for that space. On August 24, 2015, we entered into a new office lease for our corporate headquarters in Campbell, California which became effective on October 1, 2015, is better suited to our California operations and results in significant monthly savings. We were required to pre-pay a portion of the lease commitment in the form of a deposit which was recorded as deferred rent during 2015. As of December 31, 2015 deferred rent was: Component Current Liabilities Long-Term Liabilities Total Deferred rent expense $ (18,700 ) $ (46,100 ) $ (64,800 ) Deferred rent benefit 39,700 72,800 112,500 $ 21,000 $ 26,700 $ 47,700 As of December 31, 2014 deferred rent was: Component Current Liabilities Long-Term Liabilities Total Deferred rent expense $ 4,800 $ 45,700 $ 50,500 Deferred rent benefit 39,700 112,500 152,200 $ 44,500 $ 158,200 $ 202,700 Deferred rent expense represents the remaining balance of the aggregate free rent we received from our landlord and escalations that are being recognized over the life of the lease as a component of rent expense. Deferred rent benefit relates to the unamortized portion of the leasehold improvements provided to us by our landlord (i.e., incentives) that we are recognizing on a straight-line basis as a reduction to rent expense over the term of the lease.

Liability Attributable to Warra

Liability Attributable to Warrants	12 Months Ended
	Dec. 31, 2015
Other Liabilities Disclosure [Abstract]
Liability Attributable to Warrants	8. Liability Attributable to Warrants On January 7, 2014, we entered into a securities purchase agreement (the “SPA”) with a limited number of institutional investors, pursuant to which we issued and sold for cash an aggregate 753,333 shares of our common stock at a purchase price of $4.50 per share (See Note 9) (the “2014 Transaction”). We also issued warrants to the investors for no additional consideration to purchase an aggregate 376,667 shares of our common stock at an exercise price of $6.00 per share from January 7, 2014 through January 7, 2019. Under certain conditions of the SPA that were to expire no later than January 7, 2015, we could have been required to issue a variable number of additional warrants to the investors at a below-market value exercise price. Accordingly, we have concluded that the warrants issued to the investors are not indexed to our common stock; therefore, the fair value of these warrants has been recorded as a liability. Since these conditions did not occur as of January 7, 2015, we have reclassified the warrant from liability to equity. Using a binomial pricing model, we calculated the fair value of the warrants issued to the investors on January 7, 2015 to be $407,300. We used the following assumptions in the binomial pricing model to derive the fair value: estimated volatility 113%; annualized forfeiture rate 0%; expected term 4.1 years; estimated exercise factor 3.5; risk free interest rate 1.20; and dividends 0. Changes in fair value of the warrants liability are recognized in other income, except for changes in the fair value of the warrants issued to ipCapital which are recognized as a component of general and administrative expense in the consolidated statement of operations. We used the exercise price of the warrants, as well as the fair market value of our common stock, to determine the fair value of our warrants. The exercise price for warrants issued in conjunction with a 2011 transaction, including those issued to the placement agent, was either $3.00 or $3.90 per share, and was $3.90 per share for the warrants issued to ipCapital. The warrants issued to the placement agent included anti-dilution provisions for repricing of the warrants in the event that future issuances of stock by hopTo met certain conditions. The 2015 Transaction (Note 9) met those conditions and resulted in the placement agent warrants being repriced from $3.00 and $3.90 to $2.55 and $3.30, respectively. We used a binomial pricing model to determine the fair value of our warrants liability as of December 31, 2015 and 2014, the balance sheet dates, respectively, using the following assumptions: For the Year Ended December 31, 2015 Warrants Estimated Volatility Annualized Forfeiture Rate Expected Option Term (Years) Estimated Exercise Factor Risk-Free Interest Rate Dividends 2011 Private Placement 104% - 132% — 1.61 – 0.68 3.5 0.26% - 0.47% — ipCapital 105% - 127% — 1.79 – 0.79 4.0 0.26% - 0.54% — For the Year Ended December 31, 2014 Warrants Estimated Volatility Annualized Forfeiture Rate Expected Option Term (Years) Estimated Exercise Factor Risk-Free Interest Rate Dividends 2011 Private Placement 91% - 104% — 2.67 – 1.69 3.5 0.41% - 0.56% — 2014 Private Placement 114% - 157% — 5.00 - 4.08 3.5 1.35% - 1.69% — ipCapital 92% - 127% — 3.79 – 1.81 4 0.43% - 0.61% — The following table is a reconciliation of the warrants liability measured at fair value using significant unobservable inputs (Level 3) for the year ended December 31, 2015: Warrants liability – December 31, 2014 fair value $ 647,300 Change in fair value of warrant liability recorded in other income (190,300 ) Change in fair value of warrant liability recorded in general and administrative expense (18,100 ) Reclassification of 2014 PIPE Warrant to Equity (407,300 ) Warrants liability – December 31, 2015 fair value $ 31,600 The following tables reconcile the number of warrants outstanding for the periods indicated: For the Year Ended December 31, 2015 Beginning Outstanding Issued Exercised Cancelled / Forfeited Ending Outstanding 2011 Transaction 686,833 — — 686,833 2014 Transaction 376,667 — — — 376,667 ipCapital 26,667 — — — 26,667 Exercise Agreement 300,000 — — — 300,000 Consultant Warrant 11,285 — — — 11,285 Offer to Exercise 10,167 — — — 10,167 1,411,619 — — — 1,411,619 During the year ended December 31, 2015, our warrants liability was reduced by $407,300 as a result of the above mentioned reclassification of 2014 PIPE from liability warrant to equity. The aggregate reduction in the liability was $615,700. See Note 14. For the Year Ended December 31, 2014 Beginning Outstanding Issued Exercised Cancelled / Forfeited Ending Outstanding 2011 Transaction 753,500 — (66,667 ) — 686,833 2014 Transaction — 376,667 — — 376,667 ipCapital 26,667 — — — 26,667 Exercise Agreement 300,000 — — — 300,000 Consultant Warrant (1) 20,833 — — (9,548 ) 11,285 Offer to Exercise 10,167 — — — 10,167 1,111,167 376,667 (66,667 ) (9,548 ) 1,411,619 (1) Effective September 18, 2013, we entered into a consulting agreement with Genesis Select to provide us with a variety of investor relations services. As part of their compensation, we issued to them a warrant to purchase 312,500 shares of our common stock at an exercise price of $0.50 per share. The warrant will vest, monthly, over the initial twelve-month service period of the contract, assuming that the agreement remains in-force, with the first vesting having occurred on October 18, 2013. The warrant is substantially similar in nature to those issued in the warrant amendment, discussed above, thus; the warrant is accounted in equity and is not included as a component of our warrants liability as of December 31, 2013. We used the following assumptions in a binomial pricing model to calculate the fair value of the warrant issued to Genesis: estimated volatility 181%; expected term 4.96 years; estimated exercise factor 4, risk free interest rate 1.41%; and dividends 0. Expense associated with this warrant is recognized as a component of general and administrative expense over the one-year vesting term of the warrant. Effective April 11, 2014, we cancelled our consulting agreement with Genesis Select. Under the terms of the agreement, 169,273 of the warrants that had been issued the firm had vested as of the effective cancellation date.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Stockholders' Equity	9. Stockholders’ Equity Common Stock On July 24, 2015 we entered into a securities purchase agreement and subscription agreement, pursuant to which we issued and sold for cash an aggregate of 2,105,919 shares of our common stock at a purchase price of $1.21 per share. We derived gross proceeds of $2,550,500 from this placement. During 2015, we granted 57,911 options to purchase common stock to our Chief Financial Officer at a weighted average exercise price of $1.80 per share. During 2015, we awarded 15,000 shares of restricted common stock to employees. The valuation of the restricted common stock awards was based on the closing fair market value of our common stock on the grant date. For the awards made to employees, such fair market value ranged from $1.95 to $2.40 per share. On January 7, 2014, we issued and sold for cash an aggregate 753,333 shares of our common stock at a purchase price of $4.50 per share in the 2014 Transaction that resulted in gross proceeds of $3,390,000 (See Note 4). Gross cash proceeds $ 3,390,000 Less: gross proceeds allocated to warrants liability – investors (1,356,000 ) Gross proceeds allocated to additional paid-in capital and common stock 2,034,000 Less: cash issuance costs – legal fees (20,000 ) Recorded in additional paid-in capital and common stock $ 2,014,000 In conjunction with the 2014 Transaction, we recorded a warrant liability of $1,356,000 as of January 7, 2014 on our Balance Sheet (See Note 8). During 2014, the Company granted 160,000 options to purchase common stock to three directors and our Chief Executive Officer at a weighted average exercise price of $2.40 per share, and 3,333 to employees at an exercise price of $1.95 per share. We repriced stock options of 20,000 shares from exercised price $5.55 per share to $2.40 per share and 46,667 shares from $5.55 per share to $1.80 per share for two directors. Also, the Company issued 17,121 shares of common stock as a result of the exercise of employee stock options, at an average exercise price of $2.85 per share, which resulted in $3,187 of proceeds to the Company. During 2014, the Company awarded 291,300 shares of restricted common stock to employees, and 167 to a consultant. Restricted shares vest ratably over a 33-month period commencing in the fourth month after the grant date. Upon a grantee’s termination of service to us prior to full vesting any unvested shares will be cancelled. The fair market value of the awards made to employees ranged from $1.65 to $5.10 per share, and the fair market value of the awards made to consultant at $3.00. During 2014, the Company issued 66,667 shares of common stock as a result of the exercise of warrants, at an average exercise price of $3.90, which resulted in $260,000 of proceeds to the Company. Stock Repurchase Program During the years ended December 31, 2015 and 2014, the Company did not repurchase any of its common stock under the terms of its Board-approved $1,000,000 stock repurchase program (“stock repurchase program”). On November 18, 2015, our Board of Directors decided to terminate this program. At the time of termination, approximately $782,600 remained available for future purchases under this program. Stock-Based Compensation Plans Active Plans 2012 Equity Incentive Plan In the case of a restricted stock award, the entire number of shares subject to such award would be issued at the time of the grant and subject to vesting provisions based on time or other conditions specified by the Board or an authorized committee of the Board. For awards based on time, should the grantee’s service to the Company end before full vesting occurred, all unvested shares would be forfeited and returned to the Company. In the case of awards granted with vesting provisions based on specific performance conditions, if those conditions were not met, then all shares would be forfeited and returned to the Company. Until forfeited, all shares issued under a restricted stock award would be considered outstanding for dividend, voting and other purposes. Under the 12 Plan, the exercise price of non-qualified stock options granted is to be no less than 100% of the fair market value of the Company’s common stock on the date the option is granted. The exercise price of incentive stock options granted is to be no less than 100% of the fair market value of the Company’s common stock on the date the option is granted provided, however, that if the recipient of the incentive stock option owns greater than 10% of the voting power of all shares of the Company’s capital stock then the exercise price will be no less than 110% of the fair market value of the Company’s common stock on the date the option is granted. The purchase price of the restricted stock issued under the 12 Plan shall also not be less than 100% of the fair market value of the Company’s common stock on the date the restricted stock is granted. All options granted under the 12 Plan are immediately exercisable by the optionee; however, there is a vesting period for the options. The options (and the shares of common stock issuable upon exercise of such options) vest, ratably, over a 33-month period; however, no options (and the underlying shares of common stock) vest until after three months from the date of the option grant. The exercise price is immediately due upon exercise of the option. The maximum term of options issued under the 12 Plan is ten years. Shares issued upon exercise of options are subject to the Company’s repurchase, which right lapses as the shares vest. The 12 Plan will terminate no later than November 7, 2022. During the year ended December 31, 2015, options to purchase 57,911 shares of common stock, with a weighted average grant date fair value of $1.80, were granted under the 12 Plan, 15,000 shares of restricted common stock, with a weighted average grant date fair value of $2.35 were granted, no options had been exercised and 189,609 shares of common stock remained available for issuance under the 12 Plan. No options previously issued under the 12 Plan were exercised during the year ended December 31, 2015. Grant to Consultant Inactive Plans The following table summarizes options outstanding as of December 31, 2015 and 2014 that were granted from stock based compensation plans that are inactive. As of December 31, 2015 such plans can no longer grant options. Options Outstanding Year Beginning of Year Granted Exercised Cancelled End of Year 2008 Stock Option Plan 2015 430,000 — (6,000 ) (28,455 ) 395,545 2005 Equity Incentive Plan 2015 17,333 — — (3,333 ) 14,000 Supplemental Stock Option Agreement 2015 333 — — — 333 447,666 — (6,000 ) (31,788 ) 409,878 2008 Stock Option Plan 2014 641,255 — (16,455 ) (194,800 ) 430,000 2005 Equity Incentive Plan 2014 64,833 — (667 ) (46,833 ) 17,333 1998 Stock Option/Stock Issuance Plan 2014 — — — Supplemental Stock Option Agreement 2014 333 — — — 333 706,421 — (17,122 ) (241,633 ) 447,666 Summary – All Plans A summary of the status of all of the options outstanding under all of the Company’s stock option plans, and non-plan grants to consultants, as of December 31, 2015 and 2014, and changes during the years then ended, is presented in the following table: 2015 2014 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Beginning 685,867 $ 2.70 801,289 $ 3.15 Granted 57,911 $ 1.80 230,000 $ 2.10 Exercised (6,000 ) $ 0.79 (17,121 ) $ 2.85 Forfeited or expired (31,788 ) $ 3.26 (328,301 ) $ 3.60 Ending 705,990 $ 2.63 685,867 $ 2.70 Exercisable at year-end 705,990 2.63 685,867 $ 2.70 Vested or expected to vest at year-end 704,763 $ 2.64 676,299 $ 2.70 Weighted average fair value of options granted during the period $ 2.63 $ 2.70 As of December 31, 2015 and 2014, of the options exercisable, 526,648 and 414,184 were vested, respectively. The following table summarizes information about stock options outstanding as of December 31, 2015: Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $0.75-$1.80 104,111 7.10 $ 1.35 58,789 $ 1.01 $1.82-$1.82 93,333 8.42 $ 1.82 37,475 $ 1.82 $2.06-$2.40 73,000 6.67 $ 2.28 70,778 $ 2.29 $2.48-$2.48 7,333 1.04 $ 2.48 7,333 $ 2.48 $2.54-$2.54 113,333 8.92 $ 2.54 37,778 $ 2.54 $2.55-$3.00 80,667 6.04 $ 2.71 80,667 $ 2.71 $3.03-$3.30 45,600 5.32 $ 3.08 45,600 $ 3.08 $3.45-$3.45 106,412 5.83 $ 3.45 106,412 $ 3.45 $4.20-44.20 80,000 5.69 $ 4.20 80,000 $ 4.20 $5.70-$6.88 2,201 5.97 $ 6.38 1,816 $ 6.32 $0.75-$6.68 705,990 6.87 $ 2.63 526,648 $ 2.81 As of December 31, 2015, there were outstanding options to purchase 705,990 shares of common stock with a weighted average exercise price of $2.63 per share, a weighted average remaining contractual term of 6.87 years and an aggregate intrinsic value of $4,710. Of the options outstanding as of December 31, 2015, 526,648 were vested, 178,114 were estimated to vest in future periods and 1,228 were estimated to be forfeited or to expire in future periods. As of December 31, 2015, there was approximately $165,200 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested options. That cost is expected to be recognized over a weighted-average period of approximately twelve months. During 2015, the Company awarded 15,000 shares of restricted common stock, which vest ratably, over a 33-month period; however, no shares vest until after three months from the date of the restricted stock award. The Company includes the common stock underlying the restricted stock award in shares outstanding once the common stock underlying the restricted stock award has vested and the restriction has been removed (“releases” or “released”). A summary of the status of all of the Company’s unreleased restricted stock awards as of December 31, 2015 and 2014 and changes during the years then ended, is summarized in the following table. 2015 2014 Shares Weighted Average Fair Value Shares Weighted Average Fair Value Beginning unreleased 287,666 $ 2.66 262,562 $ 4.20 Awarded 15,000 $ 2.35 291,467 $ 2.46 Released (116,500 ) $ 3.09 (98,319 ) $ 3.75 Forfeited (79,580 ) $ 2.42 (168,044 ) $ 3.75 Ending unreleased 106,586 $ 2.31 287,666 $ 2.70 Of the restricted stock awards unreleased at December 31, 2015, 77,062 were estimated to be released in future periods and 29,524 were estimated to be forfeited in future periods. The aggregate fair market value of the unreleased restricted stock awards at December 31, 2015, based on the closing price of our stock as of such date of $0.90 was $95,900. As of December 31, 2015, there was approximately $213,000 of total unrecognized compensation cost, net of estimated forfeitures, related to unreleased restricted stock awards. That cost is expected to be recognized over a weighted-average period of approximately two years.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The components of the provision (benefit) for income taxes for the years ended December 31, 2015 and 2014 consisted of the following: 2015 2014 Current Federal $ — $ — State — — Foreign 3,700 3,100 $ 3,700 $ 3,100 Deferred Federal $ — $ — State — — Foreign — — — — Total $ 3,700 $ 3,100 The following table summarizes the differences between income tax expense and the amount computed applying the federal income tax rate of 34% for the years ended December 31, 2015 and 2014: 2015 2014 Federal income tax (benefit) at statutory rate $ (1,491,600 ) $ (1,217,600 ) State income tax (benefit) at statutory rate (8,100 ) (5,600 ) Foreign tax rate differential 700 5,100 Compensation from exercise of non-qualified stock options and restricted stock awards 3,400 2,100 SBC – NQ cancellations 23,500 151,500 Change in valuation allowance 1,469,900 1,530,100 Warrant liability (65,100 ) (548,400 ) Meals and entertainment (50%) 7,700 11,600 Tax rate changes (2,500 ) (1,000 ) Other items 65,800 75,300 Provision (benefit) for income tax $ 3,700 $ 3,100 Deferred income taxes and benefits result from temporary timing differences in the recognition of certain expense and income items for tax and financial reporting purposes. The following table sets forth those differences as of December 31, 2015 and 2014: 2015 2014 Net operating loss carryforwards $ 21,032,900 $ 19,483,000 Tax credit carryforwards 1,047,300 1,047,000 Depreciation and amortization (20,400 ) 55,000 Compensation expense – non-qualified stock options 729,500 588,000 Deferred revenue and maintenance service contracts 1,344,400 1,541,000 Warrant liability 800 7,000 Reserves and other 157,300 217,000 Total deferred tax assets 24,291,800 22,938,000 Deferred tax liability – capitalized software (3,900 ) (120,000 ) Net deferred tax asset 24,287,900 22,818,000 Valuation allowance (24,287,900 ) (22,818,000 ) Net deferred tax asset $ — $ — For financial reporting purposes, with the exception of the year ended December 31, 2007, the Company has incurred a loss in each year since inception. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its net deferred tax assets at December 31, 2015 and 2014. The net change in the valuation allowance was $(1,469,900) and $(1,530,100) for the years ended December 31, 2015 and 2014, respectively. At December 31, 2015, At December 31, 2015, the Company had approximately $1 million of federal research and development tax credits that will begin to expire in 2018.

Concentration of Credit Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2015
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	11. Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and trade receivables. The Company places cash and, when applicable, cash equivalents, with high quality financial institutions and, by policy, limits the amount of credit exposure to any one financial institution. As of December 31, 2015, the Company had approximately $1,559,900 of cash with financial institutions in excess of FDIC insurance limits. As of December 31, 2014, the Company had approximately $1,316,600 of cash with financial institutions in excess of FDIC insurance limits. For the years ended December 31, 2015 and December 31, 2014, the Company considered the following to be its most significant customers: 2015 2014 Customer % Sales % Accounts Receivable % Sales % Accounts Receivable Centric Systems 5.0 % 13.2 % 4.3 % 3.2 % Elosoft 10.9 % 14.8 % 5.7 % 6.9 % IDS LLC 5.8 % - 4.2 % 0.4 % KitASP 3.8 % 16.1 % 1.8 % 0.0 % Raytheon 9.4 % 1.6 % 1.1 % 0.0 % Thermo LabSystems 2.9 % 7.8 % 4.4 % 6.8 % Uniface 5.3 % 1.9 % 2.0 % 0.8 % Xerox 3.3 % 7.6 % 2.1 % 0.0 % Total 46.4 % 63.0 % 25.6 % 18.1 % The Company performs credit evaluations of customers’ financial condition whenever necessary, and does not require cash collateral or other security to support customer receivables.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies Operating Leases On August 24, 2015, we entered into a new office lease for our corporate headquarters in Campbell, California which became effective on October 1, 2015, is better suited to our California operations and results in significant monthly savings. The term of this lease is from October 1, 2015 through September 30, 2018. On February 1, 2014, we had previously relocated our corporate offices to a larger suite within our landlord’s office complex on South Bascom Avenue in Campbell, California. We are currently leasing 10,659 square feet under a five-year lease that, unless renewed, will expire in October 2018. On August 11, 2015 we entered into a sublease agreement to sublease the entirety of the South Bascom office space to a third party. The term of the sublease extends from November 1, 2015 through the end of our office lease term for that space in October, 2018. The monthly rent payments due to hopTo under this sublease fully offset the monthly rent payments due to the landlord under hopTo’s lease for that space. The following table sets forth the net minimum lease payments we will be required to make throughout the remainder of these leases: Year Ending December 31, 2016 $ 111,100 2017 114,300 2018 68,300 $ 293,700 Rent expense aggregated approximately $396,400 and $477,940 for the years ended December 31, 2015 and 2014, respectively. Contingencies. The Company enters into indemnification provisions under (i) its agreements with other companies in its ordinary course of business, including contractors and customers and (ii) its agreements with investors. Under these provisions, the Company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Company’s activities or, in some cases, as a result of the indemnified party’s activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by the Company with regard to intellectual property rights, and often survive termination of the underlying agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes the estimated fair value of these agreements is minimal. Accordingly, the Company has no liabilities recorded for these agreements as of December 31, 2015. The Company’s software license agreements also generally include a performance guarantee that the Company’s software products will operate substantially as described in the applicable program documentation for a period of 90 days after delivery. The Company also generally warrants that services that the Company performs will be provided in a manner consistent with reasonably applicable industry standards. To date, the Company has not incurred any material costs associated with these warranties and has no liabilities recorded for these agreements as of December 31, 2015. Employment Agreement – Eldad Eilam On August 21, 2013, our Board of Directors and Compensation Committee approved a new employment agreement for Eldad Eilam, our President and Chief Executive Officer. Under the employment agreement, Mr. Eilam will receive an annual base salary of $275,000 and will be eligible for a performance-based bonus in the discretion of our Compensation Committee. For 2015, Mr. Eilam is eligible for a bonus of up to $75,000. The employment agreement modified the vesting provisions of restricted shares and stock options that had previously been awarded to Mr. Eilam. Under such modified vesting provisions, which previously only accelerated in connection with a termination without cause and only in certain specified change of control situations, if Mr. Eilam’s employment is terminated as a result of death or disability, by the Company without cause, or by Mr. Eilam for good reason, or following a change in control, then all of Mr. Eilam’s unvested restricted shares and stock options shall immediately vest. Mr. Eilam is an at-will employee, however, in the event that Mr. Eilam’s employment is terminated by the Company without cause, or Mr. Eilam terminates his employment for good reason or following a change in control, then, in addition to the vesting of Mr. Eilam’s unrestricted shares and stock options as noted above, Mr. Eilam shall receive his base salary for a period of 12 months and shall also receive payment or reimbursement for a period of 12 months of the full cost to Mr. Eilam of any Company provided health insurance that Mr. Eilam elects to obtain for Mr. Eilam and any of his eligible dependents. As a condition to Mr. Eilam receiving such payments, Mr. Eilam will have to execute and deliver to the Company a general release. At all times that Mr. Eilam is an employee of the Company, the Company, at its own expense, shall provide life insurance on Mr. Eilam’s life with a death benefit in an amount not less than $1,000,000 and shall also maintain long-term disability insurance on Mr. Eilam.

Employee 401(k) Plan

Employee 401(k) Plan	12 Months Ended
	Dec. 31, 2015
Compensation and Retirement Disclosure [Abstract]
13. Employee 401(k) Plan	13. Employee 401(k) Plan In December 1998, the Company adopted a 401(k) Plan (the “Plan”), to provide retirement benefits for employees. As allowed under Section 401(k) of the Internal Revenue Code, the Plan provides tax-deferred salary deductions for eligible employees. Employees may contribute up to 15% of their annual compensation to the Plan, limited to a maximum annual amount as set periodically by the Internal Revenue Service. In addition, the Company may make discretionary/matching contributions. During 2015 and 2014, the Company contributed a total of approximately $44,000 and $60,200, to the Plan, respectively.

Supplemental Disclosure of Cash

Supplemental Disclosure of Cash Flow Information	12 Months Ended
	Dec. 31, 2015
Supplemental Cash Flow Elements [Abstract]
Supplemental Disclosure of Cash Flow Information	14. Supplemental Disclosure of Cash Flow Information The following table presents supplemental disclosure information for the statements of cash flows for the years ended December 31, 2015 and 2014: 2015 2014 Cash Paid: Income Taxes (1) $ 4,400 $ 3,400 Interest — — (1) All such disbursements were for the payment of foreign income taxes. During 2015, we incurred $182,400 of impairment loss from writing down certain capitalized software development cost that were associated with our consumer products. During 2015, the Company reduced its warrants liability by $615,700, of which $208,400 was recorded in the Consolidated Statement of Operations. During 2015, we incurred $116,400 of issuance cost for our 2015 Transaction funding for which $30,000 of cash was not disbursed. During 2015, we reclassed our short-term security deposit for our Campbell Avenue lease of $40,700 from non-current other assets to prepaid. During 2014, the Company capitalized $61,000 of property and equipment for which no cash was disbursed. The Company reported this amount as a component of accounts payable. During 2014, the Company reduced its warrants liability by $332,500. This reduction consisted of $1,624,300 charged to other income, $64,200 recorded in general and administrative expense, all of which was partially offset by the issuance of warrants totaling $1,356,000. During 2014, the Company capitalized $106,600 of property and equipment for which no cash was disbursed. The Company recorded $84,200 of such amount to long term liabilities – deferred rent and $22,400 of such amount to current liabilities – deferred rent. During 2014, the Company entered a capital lease associated with capitalized software purchased for the administration of hopTo Work licenses. As part of this transaction $16,500 was capitalized to capitalized software and $8,400 was capitalized to prepaid expenses. The total amount financed under this capital lease is $24,900 and the remaining balance as of December 31, 2014 was $22,900.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	15. Related Party Transactions ipCapital Group, Inc. On October 11, 2011, we engaged ipCapital Group, Inc. (“ipCapital”), an affiliate of John Cronin, who is one of our directors, to assist us in the execution of our strategic decision to significantly strengthen, grow and commercially exploit our intellectual property assets. Our engagement agreement with ipCapital, which has been amended three times, affords us the right to request ipCapital to perform a number of diverse services, employing its proprietary processes and methodologies, to facilitate our ability to identify and extract from our current intellectual property base new inventions, potential patent applications, and marketing and licensing opportunities. For the years ended December 31, 2015 and 2014, there were no services performed, additional charges incurred or payments made to ipCapital under the agreement. In addition to the fees we agreed to pay ipCapital for its services, we issued ipCapital a five-year warrant to purchase up to 26,667 shares of our common stock at an initial price of $3.90 per share. Half of the warrant (13,333 shares) has a time-based vesting condition, with such vesting to occur in three equal annual installments. The first, second, and third vesting installments occurred on October 11, 2012, 2013, and 2014. The remaining 13,333 shares became fully vested upon the completion to our satisfaction of all services that we requested from ipCapital under the engagement agreement, prior to the signing of the amendments. Such performance was deemed satisfactory during 2012. We believe that these fees, together with the issuance of the warrant, constitute no greater compensation than we would be required to pay an unaffiliated person for substantially similar services. The exercise price of the warrant issued to ipCapital could be reset to below-market value. Consequently, we have concluded that such warrant is not indexed to our common stock; thus, we will accrete the fair value of the warrant as a liability over the anticipated service period. Additionally, in accordance with the liability method of accounting, we will re-measure the fair value of the then-outstanding warrant at each future balance sheet date and recognize the change in fair value as general and administrative compensation expense. (See Note 8) We recognized $(18,100) and $(64,200) as a component of general and administrative expense during the years ended December 31, 2015 and 2014, respectively, resulting from the change in fair value. ipCapital Licensing Company I, LLC On February 4, 2013, we entered into an IP Brokerage agreement with ipCapital Licensing Company I, LLC (“ipCLC”). At the time that we entered into this agreement, John Cronin was a partner at ipCLC. He is no longer affiliated with ipCLC. Pursuant to the agreement, we have engaged ipCLC, on a no-retainer basis, to identify and present us with candidates who may be seeking to acquire a certain limited group of our patents unrelated to our current business strategy. If during the applicable term we enter into an agreement with any candidate presented by ipCLC to acquire or otherwise exploit the covered patents, we will pay ipCLC a fee of ten percent (10%) of the royalties, fees, and other consideration paid over the life of the agreement. The agreement is effective as of February 4, 2013, and will end 18 months after we or ipCLC served 60 days written notice of termination to the other party (with earlier termination possible in the event of a material breach). The agreement provides for customary confidentiality undertakings, limitations on ipCLC’s total liability and mutual indemnification provisions. We paid no compensation to ipCLC under the terms of the IP Brokerage Agreement during the years ended December 31, 2015 and 2014, respectively and no amounts were due ipCLC under its terms as of December 31, 2015. We believe the terms of the agreement are fair and reasonable to us and are at least as favorable as those that could be obtained on an arms’ length basis.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2015
Segment Reporting [Abstract]
Segment Information	16. Segment Information The Company’s operations have historically been conducted and reported in two segments, GO-Global and hopTo, each representing a specific product line and dedicated operating resources. During the fourth quarter of 2014, the Company developed its hopTo Work product and go to market strategy, and beginning in January of 2015, it reorganized to a functional organization structure with consolidated decision-making authority over engineering, product management, sales and marketing resources. Resources in these functional departments are now shared for the development, sales and support of both the GO-Global and hopTo products. The GO-Global and hopTo Work products also have similar target customers, distribution channels, and common reseller partners. Beginning with the three-month period ended March 31, 2015, the Company will no longer report financial results in two segments. Software revenue and services revenue for the hopTo Work product will be included in the Windows software and Windows services revenue, respectively. Revenue by country for the years ended December 31, 2015 and 2014 was as follows: Years Ended December 31, Revenue by Country 2015 2014 United States $ 2,267,600 $ 2,501,800 Brazil 666,400 669,100 Other Countries 2,047,000 2,382,500 Total $ 4,981,000 $ 5,553,400

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Event	17. Subsequent Event On January 27, 2016, we filed an amendment of our Amended and Restated Certificate of Incorporation, as amended, to effect a 1-for-15 reverse stock split of our common stock (the “Reverse Stock Split”). The Reverse Stock Split became effective in the stock market upon commencement of trading on January 28, 2016. As a result of the Reverse Stock Split, every fifteen shares of our pre-Reverse Stock Split common stock were combined and reclassified into one share of our common stock. No fractional shares were issued in connection with the Reverse Stock Split, and cash paid to stockholders for potential fractional shares was insignificant. The number of shares of common stock subject to outstanding options, restricted stock units, warrants and convertible securities were also reduced by a factor of fifteen as of January 27, 2016. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the Reverse Stock Split. The authorized number of shares and the par value per share of our common stock were not affected by the Reverse Stock Split.

Significant Accounting Polici24

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates
Cash Equivalents	Cash Equivalents
Property and Equipment	Property and Equipment
Shipping and Handling	Shipping and Handling
Software Development Costs	Software Development Costs “Costs of Software to be Sold, Leased or Marketed,”
Revenue Recognition	Revenue Recognition Software license revenues are recognized when: ● Persuasive evidence of an arrangement exists (i.e., when the Company signs a non-cancelable license agreement wherein the customer acknowledges an unconditional obligation to pay, or upon receipt of the customer’s purchase order) and ● Delivery has occurred or services have been rendered and there are no uncertainties surrounding product acceptance (i.e., when title and risk of loss have been transferred to the customer, which generally occurs when the media containing the licensed program(s) is provided to a common carrier or, in the case of electronic delivery, when the customer is given access to the licensed programs), and ● The price to the customer is fixed or determinable, as typically evidenced in a signed non-cancelable contract, or a customer’s purchase order, and ● Collectability is probable. If collectability is not considered probable, revenue is recognized when the fee is collected. Revenue recognized on software arrangements involving multiple deliverables is allocated to each deliverable based on vendor-specific objective evidence (“VSOE”) or third party evidence of the fair values of each deliverable; such deliverables include licenses for software products, maintenance, private labeling fees, or customer training. The Company limits its assessment of VSOE for each deliverable to either the price charged when the same deliverable is sold separately or the price established by management having the relevant authority to do so, for a deliverable not yet sold separately. If sufficient VSOE of fair value does not exist, so as to permit the allocation of revenue to the various elements of the arrangement, all revenue from the arrangement is deferred until such evidence exists or until all elements are delivered. If VSOE of the fair value does not exist and the only undelivered element is maintenance, then we recognize revenue on a ratable basis. If VSOE of the fair value of all undelivered elements exists but evidence does not exist for one or more delivered elements, then revenue is recognized using the residual method. Under the residual method, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is recognized as revenue. Certain resellers (“stocking resellers”) purchase product licenses that they hold in inventory until they are resold to the ultimate end-user (an “inventory stocking order”). At the time that a stocking reseller places an inventory stocking order, no product licenses are shipped by the Company to the stocking reseller rather, the stocking reseller’s inventory is credited with the number of licenses purchased and the stocking reseller can resell (issue) any number of licenses from their inventory at any time. Upon receipt of an order to issue one or more licenses from a stocking reseller’s inventory (a “draw down order”), the Company will ship the licenses(s) in accordance with the draw down order’s instructions. The Company defers recognition of revenue from inventory stocking orders until the underlying licenses are sold and shipped to the end user, as evidenced by the receipt and fulfillment of the stocking reseller’s draw down order, assuming all other revenue recognition criteria have been met. There are no rights of return granted to purchasers of the Company’s software products. Revenue is recognized from maintenance contracts ratably over the related contract period, which generally ranges from one to five years. All of the Company’s software licenses are denominated in U.S. dollars.
Deferred Rent	Deferred Rent Incentives received upon entering into the lease agreement are recognized on a straight-line basis as a reduction to rent over the term of the lease. The unamortized portion of these incentives are recorded as a part of deferred rent in current or long-term liabilities, as appropriate.
Post-employment Benefits (Severance Liability)	Post-employment Benefits (Severance Liability)
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts Beginning Balance Charge Offs Recoveries Provision Ending Balance 2015 $ 32,600 $ — $ — $ (15,300 ) $ 17,300 2014 $ 42,000 $ — $ — $ (9,400 ) $ 32,600
Income Taxes	Income Taxes “Income Taxes,” The Company and one or more of its subsidiaries are subject to United States federal income taxes, as well as income taxes of multiple state and foreign jurisdictions. The Company and its subsidiaries are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to 2011. There are no tax examinations currently underway for any of the Company’s or its subsidiaries’ tax returns for years subsequent to 2010. The Company’s policy for deducting interest and penalties is to treat interest as interest expense and penalties as taxes. The Company had not accrued any amount for the payment of interest or penalties related to any uncertain tax positions at either December 31, 2015 or 2014, as its review of such positions indicated that such potential positions were minimal. Under FASB ASC 740-10-05, “Income Taxes,”
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s warrants are determined in accordance with FASB ASC 820, “Fair Value Measurement,” ● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. ● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation. As of December 31, 2015 and 2014, all of the Company’s $31,600 and $647,300 Warrants Liability reported at fair value, respectively, were categorized as Level 3 inputs (see Note 8).
Derivative Financial Instruments	Derivative Financial Instruments
Long-Lived Assets	Long-Lived Assets
Loss Contingencies	Loss Contingencies
Stock-Based Compensation	Stock-Based Compensation Compensation – Stock Compensation. Valuation and Expense Information Under FASB ASC 718-10 The Company recorded stock-based compensation expense of $757,500 and $593,000 in the years ended December 31, 2015 and 2014, respectively. No expense was capitalized related to software development. As required by FASB ASC 718-10, the Company estimates forfeitures of employee stock-based awards and recognizes compensation cost only for those awards expected to vest. Forfeiture rates are estimated based on an analysis of historical experience and are adjusted to actual forfeiture experience as needed. During 2015, we awarded 15,000 shares of restricted common stock to employees. The valuation of the restricted common stock awards was based on the closing fair market value of our common stock on the grant date. For these awards, such fair market value ranged from $1.95 to $2.40 per share. During 2015, we granted 57,911 options to purchase common stock to our Chief Financial Officer at an exercisable price of $1.80 per share. This option grant was offered as an exchange for forfeiting 44,445 of unreleased stock award that was originally awarded in May 2014. For all options granted during 2015 and 2014, the Company set the exercise price equal to the closing fair market value of the Company’s common stock as of the date of grant. The following table illustrates the non-cash stock-based compensation expense recorded during the years ended December 31, 2015 and 2014 by income statement classification: 2015 2014 Cost of revenue $ 9,000 $ 6,500 Selling and marketing expense 148,700 73,000 General and administrative expense 499,500 437,800 Research and development expense 100,300 75,700 $ 757,500 $ 593,000 The Company estimated the fair value of each option grant made during the years ended December 31, 2015 and 2014 on the date of grant using a binomial model, with the assumptions set forth in the following table: 2015 2014 Estimated volatility 103% 96% - 126% Annualized forfeiture rate 0% 0% - 6.0% Expected option term (years) 10.00 0.03 - 10.00 Estimated exercise factor 15.0 1.5 - 15.0 Approximate risk-free interest rate 0.74% 0.03% - 1.06% Expected dividend yield — — The estimated annualized forfeiture rate was based on an analysis of historical data and considered the impact of events such as work force reductions we carried out in previous years. The expected term of our stock-based awards was based on historical award holder exercise patterns and considered the market performance of our common stock and other items. The estimated exercise factor was based on an analysis of historical data; historical exercise patterns; and a comparison of historical and current share prices. The approximate risk free interest rate was based on the implied yield available on U.S. Treasury issues with remaining terms equivalent to our expected term on our stock-based awards. The Company used the average historical volatility of its daily closing price for a period of time equal in length to the expected option term for the option being issued. The period of time over which historical volatility was measured ended on the last day of the quarterly reporting period during which the stock-based award was made. The Company does not anticipate paying dividends on its common stock for the foreseeable future.
Earnings Per Share of Common Stock	Earnings Per Share of Common Stock “Earnings Per Share,”
Comprehensive Loss	Comprehensive Loss “Reporting Comprehensive Income,”
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) In November, 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes In August 2015, FASB issued ASU No. 2015-14 “ Revenue from Contracts with Customers (Topic 606)” – Deferral of the Effective Date In April 2015, FASB issued ASU No. 2015-05 “ Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” In August 2014, FASB issued Accounting Standards Update (“ASU”) No. 2014-15 “ Preparation of Financial Statements - Going Concern (Subtopic 205-40).” In June 2014, FASB issued ASU No. 2014-12 “Compensation – Stock Compensation (Topic 718)” In May 2014, FASB issued ASU No. 2014-09 “ Revenue from Contracts with Customers (Topic 606)” 1. Removes inconsistencies and weaknesses in revenue requirements. 2. Provides a more robust framework for addressing revenue issues. 3. Improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. 4. Provides more useful information to users of financial statements through improved disclosure requirements. 5. Simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within such annual period. Early adoption is not permitted. We are currently evaluating this ASU in order to determine whether or not its adoption will have a material impact on our results of operations, cash flows or financial position. In April 2014, FASB issued ASU No. 2014-08 “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)” “Presentation of Financial Statements – Discontinued Operations,”

Significant Accounting Polici25

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Schedule of Allowance for Doubtful Accounts	The following table illustrates the details of the Allowance for Doubtful Accounts for the years ended December 31, 2015 and 2014: Beginning Balance Charge Offs Recoveries Provision Ending Balance 2015 $ 32,600 $ — $ — $ (15,300 ) $ 17,300 2014 $ 42,000 $ — $ — $ (9,400 ) $ 32,600
Schedule of Employee Service Share-based Compensation Expense	The following table illustrates the non-cash stock-based compensation expense recorded during the years ended December 31, 2015 and 2014 by income statement classification: 2015 2014 Cost of revenue $ 9,000 $ 6,500 Selling and marketing expense 148,700 73,000 General and administrative expense 499,500 437,800 Research and development expense 100,300 75,700 $ 757,500 $ 593,000
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The Company estimated the fair value of each option grant made during the years ended December 31, 2015 and 2014 on the date of grant using a binomial model, with the assumptions set forth in the following table: 2015 2014 Estimated volatility 103% 96% - 126% Annualized forfeiture rate 0% 0% - 6.0% Expected option term (years) 10.00 0.03 - 10.00 Estimated exercise factor 15.0 1.5 - 15.0 Approximate risk-free interest rate 0.74% 0.03% - 1.06% Expected dividend yield — —

Capitalized Software Developm26

Capitalized Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2015
Research and Development [Abstract]
Schedule of Capitalized Software Development Costs	Capitalized software development costs as of December 31, 2015 and 2014 consisted of the following: 2015 2014 Software development costs $ 518,800 $ 1,135,900 Accumulated amortization (498,000 ) (727,200 ) $ 20,800 $ 408,700

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Schedule of Property and equipment	Property and equipment as of December 31, 2015 and 2015 consisted of the following: 2015 2014 Equipment $ 313,700 $ 306,400 Furniture & fixture 233,900 233,900 Leasehold improvements 167,600 167,600 715,200 707,900 Less: accumulated depreciation and amortization 462,700 345,400 $ 252,500 $ 362,500

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2015
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued expenses as of December 31, 2015 and 2014 consisted of the following: 2015 2014 Consulting services $ 40,200 $ 77,300 Franchise tax 3,200 3,200 Software and subscription fees 4,900 15,900 Other 21,300 19,800 $ 69,600 $ 116,200

Severance Liability (Tables)

Severance Liability (Tables)	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Summary of Cash Compensation and Medical Coverage Payments	The following table summarizes the salary continuation and medical coverage payments during the period ended December 31, 2015. Compensation Medical Coverage Total Balance at December 31, 2014 $ — — $ — Separation agreement entered into in 2015 — 17,700 17,700 Accrued interest — — — Payments — (11,800 ) (11,800 ) Balance at December 31, 2015 $ — $ 5,900 $ 5,900 Compensation Medical Coverage Total Balance at December 31, 2013 $ 62,900 — $ 62,900 Separation agreement entered into in 2015 37,500 10,600 48,100 Accrued interest 1,700 — 1,700 Payments (102,100 ) (10,600 ) (112,700 ) Balance at December 31, 2014 $ — — $ —

Deferred Rent (Tables)

Deferred Rent (Tables)	12 Months Ended
	Dec. 31, 2015
Revenue
Summary of Deferred Rent	As of December 31, 2015 deferred rent was: Component Current Liabilities Long-Term Liabilities Total Deferred rent expense $ (18,700 ) $ (46,100 ) $ (64,800 ) Deferred rent benefit 39,700 72,800 112,500 $ 21,000 $ 26,700 $ 47,700 As of December 31, 2014 deferred rent was: Component Current Liabilities Long-Term Liabilities Total Deferred rent expense $ 4,800 $ 45,700 $ 50,500 Deferred rent benefit 39,700 112,500 152,200 $ 44,500 $ 158,200 $ 202,700

Liability Attributable to War31

Liability Attributable to Warrants (Tables)	12 Months Ended
	Dec. 31, 2015
Other Liabilities Disclosure [Abstract]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques	We used a binomial pricing model to determine the fair value of our warrants liability as of December 31, 2015 and 2014, the balance sheet dates, respectively, using the following assumptions: For the Year Ended December 31, 2015 Warrants Estimated Volatility Annualized Forfeiture Rate Expected Option Term (Years) Estimated Exercise Factor Risk-Free Interest Rate Dividends 2011 Private Placement 104% - 132% — 1.61 – 0.68 3.5 0.26% - 0.47% — ipCapital 105% - 127% — 1.79 – 0.79 4.0 0.26% - 0.54% — For the Year Ended December 31, 2014 Warrants Estimated Volatility Annualized Forfeiture Rate Expected Option Term (Years) Estimated Exercise Factor Risk-Free Interest Rate Dividends 2011 Private Placement 91% - 104% — 2.67 – 1.69 3.5 0.41% - 0.56% — 2014 Private Placement 114% - 157% — 5.00 - 4.08 3.5 1.35% - 1.69% — ipCapital 92% - 127% — 3.79 – 1.81 4 0.43% - 0.61% —
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table is a reconciliation of the warrants liability measured at fair value using significant unobservable inputs (Level 3) for the year ended December 31, 2015: Warrants liability – December 31, 2014 fair value $ 647,300 Change in fair value of warrant liability recorded in other income (190,300 ) Change in fair value of warrant liability recorded in general and administrative expense (18,100 ) Reclassification of 2014 PIPE Warrant to Equity (407,300 ) Warrants liability – December 31, 2015 fair value $ 31,600
Schedule of Stockholders' Equity Note, Warrants or Rights	The following tables reconcile the number of warrants outstanding for the periods indicated: For the Year Ended December 31, 2015 Beginning Outstanding Issued Exercised Cancelled / Forfeited Ending Outstanding 2011 Transaction 686,833 — — 686,833 2014 Transaction 376,667 — — — 376,667 ipCapital 26,667 — — — 26,667 Exercise Agreement 300,000 — — — 300,000 Consultant Warrant 11,285 — — — 11,285 Offer to Exercise 10,167 — — — 10,167 1,411,619 — — — 1,411,619 During the year ended December 31, 2015, our warrants liability was reduced by $407,300 as a result of the above mentioned reclassification of 2014 PIPE from liability warrant to equity. The aggregate reduction in the liability was $615,700. See Note 14. For the Year Ended December 31, 2014 Beginning Outstanding Issued Exercised Cancelled / Forfeited Ending Outstanding 2011 Transaction 753,500 — (66,667 ) — 686,833 2014 Transaction — 376,667 — — 376,667 ipCapital 26,667 — — — 26,667 Exercise Agreement 300,000 — — — 300,000 Consultant Warrant (1) 20,833 — — (9,548 ) 11,285 Offer to Exercise 10,167 — — — 10,167 1,111,167 376,667 (66,667 ) (9,548 ) 1,411,619

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2015
Stockholders' Equity Note [Abstract]
Schedule of Stockholders Equity	Gross cash proceeds $ 3,390,000 Less: gross proceeds allocated to warrants liability – investors (1,356,000 ) Gross proceeds allocated to additional paid-in capital and common stock 2,034,000 Less: cash issuance costs – legal fees (20,000 ) Recorded in additional paid-in capital and common stock $ 2,014,000
Schedule of Share-based Compensation, Activity	The following table summarizes options outstanding as of December 31, 2015 and 2014 that were granted from stock based compensation plans that are inactive. As of December 31, 2015 such plans can no longer grant options. Options Outstanding Year Beginning of Year Granted Exercised Cancelled End of Year 2008 Stock Option Plan 2015 430,000 — (6,000 ) (28,455 ) 395,545 2005 Equity Incentive Plan 2015 17,333 — — (3,333 ) 14,000 Supplemental Stock Option Agreement 2015 333 — — — 333 447,666 — (6,000 ) (31,788 ) 409,878 2008 Stock Option Plan 2014 641,255 — (16,455 ) (194,800 ) 430,000 2005 Equity Incentive Plan 2014 64,833 — (667 ) (46,833 ) 17,333 1998 Stock Option/Stock Issuance Plan 2014 — — — Supplemental Stock Option Agreement 2014 333 — — — 333 706,421 — (17,122 ) (241,633 ) 447,666
Schedule of Share-based Compensation, Stock Options, Activity	A summary of the status of all of the options outstanding under all of the Company’s stock option plans, and non-plan grants to consultants, as of December 31, 2015 and 2014, and changes during the years then ended, is presented in the following table: 2015 2014 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Beginning 685,867 $ 2.70 801,289 $ 3.15 Granted 57,911 $ 1.80 230,000 $ 2.10 Exercised (6,000 ) $ 0.79 (17,121 ) $ 2.85 Forfeited or expired (31,788 ) $ 3.26 (328,301 ) $ 3.60 Ending 705,990 $ 2.63 685,867 $ 2.70 Exercisable at year-end 705,990 2.63 685,867 $ 2.70 Vested or expected to vest at year-end 704,763 $ 2.64 676,299 $ 2.70 Weighted average fair value of options granted during the period $ 2.63 $ 2.70
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range	The following table summarizes information about stock options outstanding as of December 31, 2015: Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $0.75-$1.80 104,111 7.10 $ 1.35 58,789 $ 1.01 $1.82-$1.82 93,333 8.42 $ 1.82 37,475 $ 1.82 $2.06-$2.40 73,000 6.67 $ 2.28 70,778 $ 2.29 $2.48-$2.48 7,333 1.04 $ 2.48 7,333 $ 2.48 $2.54-$2.54 113,333 8.92 $ 2.54 37,778 $ 2.54 $2.55-$3.00 80,667 6.04 $ 2.71 80,667 $ 2.71 $3.03-$3.30 45,600 5.32 $ 3.08 45,600 $ 3.08 $3.45-$3.45 106,412 5.83 $ 3.45 106,412 $ 3.45 $4.20-44.20 80,000 5.69 $ 4.20 80,000 $ 4.20 $5.70-$6.88 2,201 5.97 $ 6.38 1,816 $ 6.32 $0.75-$6.68 705,990 6.87 $ 2.63 526,648 $ 2.81
Schedule of Unvested Restricted Stock Units Roll Forward	A summary of the status of all of the Company’s unreleased restricted stock awards as of December 31, 2015 and 2014 and changes during the years then ended, is summarized in the following table. 2015 2014 Shares Weighted Average Fair Value Shares Weighted Average Fair Value Beginning unreleased 287,666 $ 2.66 262,562 $ 4.20 Awarded 15,000 $ 2.35 291,467 $ 2.46 Released (116,500 ) $ 3.09 (98,319 ) $ 3.75 Forfeited (79,580 ) $ 2.42 (168,044 ) $ 3.75 Ending unreleased 106,586 $ 2.31 287,666 $ 2.70

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The components of the provision (benefit) for income taxes for the years ended December 31, 2015 and 2014 consisted of the following: 2015 2014 Current Federal $ — $ — State — — Foreign 3,700 3,100 $ 3,700 $ 3,100 Deferred Federal $ — $ — State — — Foreign — — — — Total $ 3,700 $ 3,100
Schedule of Effective Income Tax Rate Reconciliation	The following table summarizes the differences between income tax expense and the amount computed applying the federal income tax rate of 34% for the years ended December 31, 2015 and 2014: 2015 2014 Federal income tax (benefit) at statutory rate $ (1,491,600 ) $ (1,217,600 ) State income tax (benefit) at statutory rate (8,100 ) (5,600 ) Foreign tax rate differential 700 5,100 Compensation from exercise of non-qualified stock options and restricted stock awards 3,400 2,100 SBC – NQ cancellations 23,500 151,500 Change in valuation allowance 1,469,900 1,530,100 Warrant liability (65,100 ) (548,400 ) Meals and entertainment (50%) 7,700 11,600 Tax rate changes (2,500 ) (1,000 ) Other items 65,800 75,300 Provision (benefit) for income tax $ 3,700 $ 3,100
Schedule of Deferred Tax Assets and Liabilities	Deferred income taxes and benefits result from temporary timing differences in the recognition of certain expense and income items for tax and financial reporting purposes. The following table sets forth those differences as of December 31, 2015 and 2014: 2015 2014 Net operating loss carryforwards $ 21,032,900 $ 19,483,000 Tax credit carryforwards 1,047,300 1,047,000 Depreciation and amortization (20,400 ) 55,000 Compensation expense – non-qualified stock options 729,500 588,000 Deferred revenue and maintenance service contracts 1,344,400 1,541,000 Warrant liability 800 7,000 Reserves and other 157,300 217,000 Total deferred tax assets 24,291,800 22,938,000 Deferred tax liability – capitalized software (3,900 ) (120,000 ) Net deferred tax asset 24,287,900 22,818,000 Valuation allowance (24,287,900 ) (22,818,000 ) Net deferred tax asset $ — $ —

Concentration of Credit Risk (T

Concentration of Credit Risk (Tables)	12 Months Ended
	Dec. 31, 2015
Risks and Uncertainties [Abstract]
Schedules of Concentration of Risk, by Risk Factor	For the years ended December 31, 2015 and December 31, 2014, the Company considered the following to be its most significant customers: 2015 2014 Customer % Sales % Accounts Receivable % Sales % Accounts Receivable Centric Systems 5.0 % 13.2 % 4.3 % 3.2 % Elosoft 10.9 % 14.8 % 5.7 % 6.9 % IDS LLC 5.8 % - 4.2 % 0.4 % KitASP 3.8 % 16.1 % 1.8 % 0.0 % Raytheon 9.4 % 1.6 % 1.1 % 0.0 % Thermo LabSystems 2.9 % 7.8 % 4.4 % 6.8 % Uniface 5.3 % 1.9 % 2.0 % 0.8 % Xerox 3.3 % 7.6 % 2.1 % 0.0 % Total 46.4 % 63.0 % 25.6 % 18.1 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments	The following table sets forth the net minimum lease payments we will be required to make throughout the remainder of these leases: Year Ending December 31, 2016 $ 111,100 2017 114,300 2018 68,300 $ 293,700

Supplemental Disclosure of Ca36

Supplemental Disclosure of Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2015
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures	The following table presents supplemental disclosure information for the statements of cash flows for the years ended December 31, 2015 and 2014: 2015 2014 Cash Paid: Income Taxes (1) $ 4,400 $ 3,400 Interest — — (1) All such disbursements were for the payment of foreign income taxes.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2015
Segment Reporting [Abstract]
Schedule of Revenue by Country	Revenue by country for the years ended December 31, 2015 and 2014 was as follows: Years Ended December 31, Revenue by Country 2015 2014 United States $ 2,267,600 $ 2,501,800 Brazil 666,400 669,100 Other Countries 2,047,000 2,382,500 Total $ 4,981,000 $ 5,553,400

Basis of Presentation (Details

Basis of Presentation (Details Narrative)	12 Months Ended
	Dec. 31, 2015Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of Operating Segments	2
Reverse stock split	1-for-15

Significant Accounting Polici39

Significant Accounting Policies (Details Narrative)	3 Months Ended	12 Months Ended
	Dec. 31, 2014USD ($)	Dec. 31, 2015USD ($)Integer$ / sharesshares	Dec. 31, 2014USD ($)$ / sharesshares
Cash equivalents, at carrying value
Capitalized computer software, additions		$ 12,000	$ 16,500
Useful life software development cost maximum		3 years
Minimum number of delivered elements for which evidence does not exist | Integer		1
Severance costs	$ 112,700	$ 42,100	48,100
Other employee related liabilities	0	5,900	0
Unrecognized tax benefits, income tax penalties and interest accrued	0	0	0
Warrants and rights outstanding	$ 647,300	31,600	647,300
Impairment of long-lived assets held-for-use		182,400	0
Allocated share-based compensation expense		757,500	593,000
Employee service share-based compensation, allocation of recognized period costs, capitalized amount		$ 0	$ 0
Option granted | shares
Number of shares that excluded from the computation of diluted earnings per share | shares		2,224,195	2,385,152
Employees [Member]
Option granted | shares			3,333
Share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price (in dollars per share) | $ / shares			$ 1.95
Three Directors And Chief Executive Officer [Member]
Option granted | shares		57,911
Option grant offered as an exchange for forfeiting | shares		44,445
Share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price (in dollars per share) | $ / shares		$ 1.80
Minimum [Member]
Property, plant and equipment, useful life		3 years
Maintenance contract period		1 year
Maximum [Member]
Property, plant and equipment, useful life		7 years
Maintenance contract period		5 years
Leasehold Improvements [Member] | Minimum [Member]
Property, plant and equipment, useful life		3 years
Leasehold Improvements [Member] | Maximum [Member]
Property, plant and equipment, useful life		7 years
Restricted Stock [Member]
Fair market value range | $ / shares		$ 2.35	2.46
Restricted Stock [Member] | Employees [Member]
Non option granted | shares		15,000
Restricted Stock [Member] | Minimum [Member] | Employees [Member]
Fair market value range | $ / shares		$ 1.95	1.65
Restricted Stock [Member] | Maximum [Member] | Employees [Member]
Fair market value range | $ / shares		$ 2.40	$ 5.10

Significant Accounting Polici40

Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Beginning Balance	$ 32,600	$ 42,000
Charge Offs
Recoveries
Provision	$ (15,300)	$ (9,400)
Ending Balance	$ 17,300	$ 32,600

Significant Accounting Polici41

Significant Accounting Policies - Schedule of Employee Service Share-based Compensation Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	$ 757,500	$ 593,000
Costs of Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	9,000	6,500
Selling and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	148,700	73,000
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	499,500	437,800
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	$ 100,300	$ 75,700

Significant Accounting Polici42

Significant Accounting Policies - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Note 2 - Significant Accounting Policies (Details) - Fair Value Assumptions of Each Stock-based Award Granted (Incomplete) [Line Items]
Estimated volatility, minimum		96.00%
Estimated volatility, maximum		126.00%
Estimated volatility	103.00%
Annualized forfeiture rate, minimum		0.00%
Annualized forfeiture rate, maximum		6.00%
Annualized forfeiture rate	0.00%
Expected option term (years)	10 years
Estimated exercise factor	$ 15
Approximate risk-free interest rate, minimum		0.03%
Approximate risk-free interest rate, maximum		1.06%
Approximate risk-free interest rate	0.74%
Expected dividend yield	0.00%	0.00%
Maximum [Member]
Note 2 - Significant Accounting Policies (Details) - Fair Value Assumptions of Each Stock-based Award Granted (Incomplete) [Line Items]
Expected option term (years)		11 days
Estimated exercise factor		$ 1.5
Minimum [Member]
Note 2 - Significant Accounting Policies (Details) - Fair Value Assumptions of Each Stock-based Award Granted (Incomplete) [Line Items]
Expected option term (years)		10 years
Estimated exercise factor		$ 15

Capitalized Software Developm43

Capitalized Software Development Costs (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Research and Development [Abstract]
Capitalized computer software, additions	$ 12,000	$ 16,500
Capitalized computer software, amortization	217,500	$ 227,200
Capitalized computer software impairments	$ 182,400

Capitalized Software Developm44

Capitalized Software Development Costs - Schedule of Capitalized Software Development Costs (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Research and Development [Abstract]
Software development costs	$ 518,800	$ 1,135,900
Accumulated amortization	(498,000)	(727,200)
Capitalized software development costs, net	$ 20,800	$ 408,700

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014
Depreciation		$ 117,300	$ 157,800
Capitalized equipment cost		7,300
Equipment [Member]
Capitalized equipment cost		35,700
Property, plant and equipment, disposals	$ 972,900
Furniture [Member]
Capitalized equipment cost		14,900
Property, plant and equipment, disposals	213,400
Leasehold Improvements [Member]
Capitalized equipment cost		$ 167,600
Property, plant and equipment, disposals	$ 147,500

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Property and equipment gross	$ 715,200	$ 707,900
Less: accumulated depreciation and amortization	462,700	345,400
Property and equipment net	252,500	362,500
Equipment [Member]
Property and equipment gross	313,700	306,400
Furniture And Fixtures [Member]
Property and equipment gross	233,900	233,900
Leasehold Improvements [Member]
Property and equipment gross	$ 167,600	$ 167,600

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Liabilities (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Consulting services	$ 40,200	$ 77,300
Franchise tax	3,200	3,200
Software and subscription fees	4,900	15,900
Other	21,300	19,800
Accrued expenses	$ 69,600	$ 116,200

Severance Liability (Details Na

Severance Liability (Details Narrative) - USD ($)	1 Months Ended
	Aug. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2014
Related Party Transactions [Abstract]
Payment made to employee medical coverage	$ 15,000
Severance liabilities		$ 5,900	$ 0	$ 62,900

Severance Liability - Summary o

Severance Liability - Summary of Cash Compensation and Medical Coverage Payments (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Balance	$ 62,900	$ 0
Separation agreement	48,100	$ 17,700
Accrued interest	1,700
Payments	(112,700)	$ (42,100)	$ (48,100)
Balance	$ 0	$ 5,900	0
Compensation [Member]
Balance			62,900
Separation agreement			37,500
Accrued interest			1,700
Payments			$ (102,100)
Balance
Medical Coverage [Member]
Balance
Separation agreement		$ 17,800	$ 10,600
Accrued interest
Payments		$ (11,800)	$ (10,600)
Balance		$ 5,900

Deferred Rent (Details Narrativ

Deferred Rent (Details Narrative)	Dec. 31, 2015USD ($)
Revenue
Leasehold improvements	$ 106,600

Deferred Rent - Summary of Defe

Deferred Rent - Summary of Deferred Rent (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Liabilities	$ 21,000	$ 44,500
Long-Term Liabilities	26,700	158,200
Total	47,700	202,700
Deferred Rent Expense [Member]
Current Liabilities	(18,700)	4,800
Long-Term Liabilities	(46,100)	45,700
Total	(64,800)	50,500
Deferred Rent Benefit [Member]
Current Liabilities	39,700	39,700
Long-Term Liabilities	72,800	112,500
Total	$ 112,500	$ 152,200

Liability Attributable to War52

Liability Attributable to Warrants (Details Narrative)	Apr. 11, 2014shares	Jan. 07, 2014$ / sharesshares	Sep. 18, 2013$ / sharesshares	Dec. 31, 2015USD ($)Integer$ / sharesshares	Dec. 31, 2014USD ($)$ / sharesshares	Jul. 24, 2015$ / shares
Class of warrant or right, exercise price of warrants or rights					$ 3.90
Warrants and rights outstanding | $				$ 31,600	$ 647,300
Class of warrant or right, fair value | $				407,300
Warrants liability, period increase (decrease) | $				$ 615,700	$ 332,500
Fair value assumptions, expected volatility rate			181.00%	113.00%
Fair value assumptions, annualized forfeiture rate				0.00%
Fair value assumptions, expected term			4 years 11 months 16 days
Fair value assumption, exercise factor | Integer				3.5
Fair value assumptions, risk free interest rate			1.41%	1.20%
Fair value assumptions, weighted average expected dividend			$ 0	$ 0
Issuance of warrants to purchase of common stock | shares			312,500
Common stock at an exercise price			$ 0.50			$ 1.21
Class of warrant or right, shares canceled (in shares) | shares	169,273				(9,548)
Securities Purchase Agreement [Member]
Class of warrant or right, number of securities called by warrants or rights | shares		376,667
Class of warrant or right, exercise price of warrants or rights		$ 6
Exercise Agreement [Member]
Fair value assumptions, expected term				4 years 1 month 6 days
Class of warrant or right, shares canceled (in shares) | shares
2011 Transaction [Member]
Class of warrant or right, shares canceled (in shares) | shares
2011 Transaction [Member] | Minimum [Member]
Class of warrant or right, exercise price of warrants or rights				$ 3
Warrants exercise price upon repricing				255.00%
2011 Transaction [Member] | Maximum [Member]
Class of warrant or right, exercise price of warrants or rights				$ 3.90
Warrants exercise price upon repricing				330.00%
Common Stock [Member] | Securities Purchase Agreement [Member]
Stock issued during period, shares, new issues | shares		753,333
Share price		$ 4.50

Liability Attributable to War53

Liability Attributable to Warrants - Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques (Details) - USD ($)	Sep. 18, 2013	Dec. 31, 2015	Dec. 31, 2014
Estimated Volatility	181.00%	113.00%
Annualized Forfeiture Rate		0.00%
Expected Term	4 years 11 months 16 days
Risk-Free Interest Rate	1.41%	1.20%
IP Capital Group Inc [Member]
Annualized Forfeiture Rate
Estimated Exercise Factor		$ 4
Dividends
2011 Private Placement [Member]
Annualized Forfeiture Rate
Estimated Exercise Factor		$ 3.5	$ 3.5
Dividends
2011 Private Placement [Member] | Minimum [Member]
Estimated Volatility		104.00%	91.00%
Expected Term		1 year 7 months 10 days	2 years 8 months 1 day
Risk-Free Interest Rate		0.26%	0.41%
2011 Private Placement [Member] | Maximum [Member]
Estimated Volatility		132.00%	104.00%
Expected Term		8 months 5 days	1 year 8 months 9 days
Risk-Free Interest Rate		0.47%	0.56%
IP Capital Group Inc [Member]
Annualized Forfeiture Rate
Estimated Exercise Factor			$ 4
Dividends
IP Capital Group Inc [Member] | Minimum [Member]
Estimated Volatility		105.00%	92.00%
Expected Term		1 year 9 months 15 days	3 years 9 months 15 days
Risk-Free Interest Rate		0.26%	0.43%
IP Capital Group Inc [Member] | Maximum [Member]
Estimated Volatility		127.00%	127.00%
Expected Term		9 months 15 days	1 year 9 months 22 days
Risk-Free Interest Rate		0.54%	0.61%
2014 Private Placement [Member]
Annualized Forfeiture Rate
Estimated Exercise Factor			$ 3.5
Dividends
2014 Private Placement [Member] | Minimum [Member]
Estimated Volatility			114.00%
Expected Term			5 years
Risk-Free Interest Rate			1.35%
2014 Private Placement [Member] | Maximum [Member]
Estimated Volatility			157.00%
Expected Term			4 years 29 days
Risk-Free Interest Rate			1.69%

Liability Attributable to War54

Liability Attributable to Warrants - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)	12 Months Ended
	Dec. 31, 2015USD ($)
Other Liabilities Disclosure [Abstract]
Warrants liability - December 31, 2014 fair value	$ 647,300
Change in fair value of warrant liability recorded in other income	(190,300)
Change in fair value of warrant liability recorded in general and administrative expense	(18,100)
Reclassification of 2014 PIPE Warrant to Equity	(407,300)
Warrants liability – December 31, 2015 fair value	$ 31,600

Liability Attributable to War55

Liability Attributable to Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - shares		Apr. 11, 2014	Dec. 31, 2015	Dec. 31, 2014
Beginning Outstanding			1,411,619	1,111,167
Issued				376,667
Exercised				(66,667)
Cancelled / Forfeited		169,273		(9,548)
Ending Outstanding			1,411,619	1,411,619
2011 Transaction [Member]
Beginning Outstanding			686,833	753,500
Issued
Exercised				(66,667)
Cancelled / Forfeited
Ending Outstanding			686,833	686,833
2014 Transaction [Member]
Beginning Outstanding			376,667
Issued				376,667
Exercised
Cancelled / Forfeited
Ending Outstanding			376,667	376,667
IP Capital Group Inc [Member]
Beginning Outstanding			26,667	26,667
Issued
Exercised
Cancelled / Forfeited
Ending Outstanding			26,667	26,667
Exercise Agreement [Member]
Beginning Outstanding			300,000	300,000
Issued
Exercised
Cancelled / Forfeited
Ending Outstanding			300,000	300,000
Consultant Warrant [Member]
Beginning Outstanding	[1]		11,285	20,833
Issued					[1]
Exercised					[1]
Cancelled / Forfeited	[1]			(9,548)
Ending Outstanding			11,285	11,285	[1]
Offer to Exercise [Member]
Beginning Outstanding			10,167	10,167
Issued
Exercised
Cancelled / Forfeited
Ending Outstanding			10,167	10,167
[1]	Effective September 18, 2013, we entered into a consulting agreement with Genesis Select to provide us with a variety of investor relations services. As part of their compensation, we issued to them a warrant to purchase 312,500 shares of our common stock at an exercise price of $0.50 per share. The warrant will vest, monthly, over the initial twelve-month service period of the contract, assuming that the agreement remains in-force, with the first vesting having occurred on October 18, 2013. The warrant is substantially similar in nature to those issued in the warrant amendment, discussed above, thus; the warrant is accounted in equity and is not included as a component of our warrants liability as of December 31, 2013. We used the following assumptions in a binomial pricing model to calculate the fair value of the warrant issued to Genesis: estimated volatility 181%; expected term 4.96 years; estimated exercise factor 4, risk free interest rate 1.41%; and dividends 0. Expense associated with this warrant is recognized as a component of general and administrative expense over the one-year vesting term of the warrant.

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Jul. 24, 2015	Jan. 07, 2014	Dec. 31, 2015	Dec. 31, 2014	Sep. 18, 2013
Note 9 - Stockholders' Equity (Details) [Line Items]
Sale of stock during period	$ 2,105,919
Sale of stock price per share	$ 1.21				$ 0.50
Sale of stock during period, value	2,550,500
Procceds from private placements			$ 2,550,500	$ 3,390,000
Share-based payment award, options, grants in period, gross
Gross proceeds allocated to warrants liability – investors			$ 1,356,000	$ (1,356,000)
Share-based compensation arrangement by share-based payment award, options, exercises in period			6,000	17,122
Proceeds from stock options exercised (in dollars)			$ 4,900	$ 47,800
Stock issued during period shares warrants exercised				66,667
Class of warrant or right, exercise price of warrants or rights (in dollars per share)				$ 3.90
Proceeds from warrant exercises (in dollars)				$ 260,000
Stock repurchase program, authorized amount (in dollars)			$ 1,000,000	1,000,000
Stock repurchase program, remaining authorized repurchase amount (in dollars)			$ 782,600	$ 782,600
Share based compensation arrangement by share based payment award options vested outstanding number			526,648	414,184
Share-based compensation, shares authorized under stock option plans, exercise price range, number of outstanding options			705,990
Share-based compensation, shares authorized under stock option plans, exercise price range, exercisable options, weighted average exercise price (in dollars per share)			$ 2.63
Share-based compensation, shares authorized under stock option plans, exercise price range, outstanding options, weighted average remaining contractual term			6 years 10 months 13 days
Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value (in dollars)			$ 4,710
Share based compensation arrangement by share based payment award options expected to vest outstanding number			178,114
Share based compensation arrangement by share based payment award options expected to be forfeited			1,228
Employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options (in dollars)			$ 165,200
Share-based compensation arrangement by share-based payment award, award vesting period			33 months
Chief Financial Officer [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based payment award, options, grants in period, gross			57,911
Weighted average exercise price			$ 1.80
Employees [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based payment award, options, grants in period, gross				3,333
Weighted average exercise price				$ 1.95
Directors [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based payment award, options, grants in period, gross				160,000
Weighted average exercise price				$ 2.40
All Stock Option Plans [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based payment award, options, grants in period, gross			57,911
Weighted average exercise price			$ 1.80
Share-based compensation arrangement by share-based payment award, options, exercises in period				17,121
Share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price (in dollars per share)				$ 2.85
Proceeds from stock options exercised (in dollars)				$ 3,187
2012 Equity Incentive Plan [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, number of shares authorized			643,797
Share-based compensation arrangement by share-based payment award, number of shares available for grant			189,609
2014 Private Placement [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Sale of stock price per share		$ 4.50
Common stock issued for cash		753,333
Procceds from private placements		$ 3,390,000
Gross proceeds allocated to warrants liability – investors		$ 1,356,000
Restricted Stock [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Fair market value range			$ 2.35	$ 2.46
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period			15,000	291,467
Awards estimated to be released in future periods			77,062
Awards estimated to be forfeited in future periods			29,524
Aggregate fair market value of unreleased stock awards (in dollars)			$ 95,900
Closing price of common stock (in dollars per share)			$ 0.90
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)			$ 213,000
Restricted Stock [Member] | Employees [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Non option granted			15,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period				291,300
Restricted Stock [Member] | Consultants [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Fair market value range				$ 3
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period			0	167
Restricted Stock [Member] | Minimum [Member] | Employees [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Fair market value range			$ 1.95	$ 1.65
Restricted Stock [Member] | Maximum [Member] | Employees [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Fair market value range			$ 2.40	5.10
Restricted Stock [Member] | 2012 Equity Incentive Plan [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period			15,000
Restricted Stock [Member] | 2012 Equity Incentive Plan [Member] | Minimum [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent			100.00%
Options Repriced From 37 Cents To 16 Cents Per Share [Member] | Two Directors [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Weighted average exercise price				$ 5.55
Options to purchase common stock, number repriced				20,000
Options to purchase common stock, exercise price after repricing (in dollars per share)				$ 2.40
Options Repriced From 37 Cents To 12 Cents Per Share [Member] | Two Directors [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Weighted average exercise price				$ 5.55
Options to purchase common stock, number repriced				46,667
Options to purchase common stock, exercise price after repricing (in dollars per share)				$ 1.80
Incentive Stock Options [Member] | 2012 Equity Incentive Plan [Member] | Minimum [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent			100.00%
Incentive Stock Options [Member] | 2012 Equity Incentive Plan [Member] | Minimum [Member] | If Recipient Owns Greater Than Ten Percentf Voting Power [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent			110.00%
Non Qualified Stock Options [Member] | 2012 Equity Incentive Plan [Member] | Minimum [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent			100.00%

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Stockholders Equity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Equity [Abstract]
Gross cash proceeds	$ 2,550,500	$ 3,390,000
Less: gross proceeds allocated to warrants liability – investors	(1,356,000)	$ 1,356,000
Gross proceeds allocated to additional paid-in capital and common stock	2,034,000
Less: cash issuance costs – legal fees	(20,000)
Recorded in additional paid-in capital and common stock	$ 2,014,000

Stockholders' Equity - Schedu58

Stockholders' Equity - Schedule of Share-based Compensation, Activity (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	447,666	706,421
Options Outstanding, Granted
Options Outstanding, Exercised	(6,000)	(17,122)
Options Outstanding, Cancelled	(31,788)	(241,633)
Options Outstanding, Balance	409,878	447,666
2008 Equity Incentive Plan [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	430,000
Options Outstanding, Granted
Options Outstanding, Exercised	(6,000)
Options Outstanding, Cancelled	(28,455)
Options Outstanding, Balance	395,545	430,000
2005 Stock Option Plan [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	17,333	64,833
Options Outstanding, Granted
Options Outstanding, Exercised		(667)
Options Outstanding, Cancelled	(3,333)	(46,833)
Options Outstanding, Balance	14,000	17,333
Supplemental Stock Option Agreement [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	333
Options Outstanding, Granted
Options Outstanding, Exercised
Options Outstanding, Cancelled
Options Outstanding, Balance	333	333
2008 Stock Option Plan [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	430,000	641,255
Options Outstanding, Exercised		(16,455)
Options Outstanding, Cancelled		(194,800)
Options Outstanding, Balance		430,000
1998 Stock Option/Stock Issuance Plan [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Inactive Plans [Line Items]
Options Outstanding, Balance	333	333
Options Outstanding, Exercised
Options Outstanding, Balance		333

Stockholders' Equity - Schedu59

Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Note 9 - Stockholders' Equity (Details) - Summary of Status of All Stock Option Plans [Line Items]
Options Outstanding, Balance	447,666	706,421
Options Outstanding, Granted
Options Outstanding, Exercised	(6,000)	(17,122)
Options Outstanding, Balance	409,878	447,666
Stock Option Plans [Member]
Note 9 - Stockholders' Equity (Details) - Summary of Status of All Stock Option Plans [Line Items]
Options Outstanding, Balance	685,867	801,289
Options Outstanding, Granted	57,911	230,000
Options Outstanding, Exercised	(6,000)	(17,121)
Options Outstanding, Forfeited or expired	(31,788)	(328,301)
Options Outstanding, Balance	705,990	685,867
Options Outstanding, Exercisable at year-end	705,990	685,867
Options Outstanding, Vested or expected to vest at year-end	704,763	676,299
Weighted Average Exercise Price, Outstanding Balance	$ 2.70	$ 3.15
Weighted Average Exercise Price, Granted	1.80	2.10
Weighted Average Exercise Price, Exercised	0.79	2.85
Weighted Average Exercise Price, Exercisable at year-end	3.26	3.60
Weighted Average Exercise Price, Forfeited or expired	2.63	2.70
Weighted Average Exercise Price, Vested or expected to vest at year-end	2.63	2.70
Weighted Average Exercise Price, Outstanding Balance	2.64	2.70
Weighted average fair value of options granted during the period	$ 2.63	$ 2.70

Stockholders' Equity - Schedu60

Stockholders' Equity - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number (in Shares) | shares	705,990
Options Exercisable, Weighted Average Exercise Price	$ 2.63
Exercise Price Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	0.75
Exercise Price Range, Upper Range Limit	$ 1.80
Options Outstanding, Number (in Shares) | shares	104,111
Options Outstanding, Weighted Average Remaining Contractual Life	7 years 1 month 6 days
Options Outstanding, Exercise Price	$ 1.35
Options Exercisable, Number Exercisable (in Shares) | shares	58,789
Options Exercisable, Weighted Average Exercise Price	$ 1.01
Exercise Price Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	1.82
Exercise Price Range, Upper Range Limit	$ 1.82
Options Outstanding, Number (in Shares) | shares	93,333
Options Outstanding, Weighted Average Remaining Contractual Life	8 years 5 months 1 day
Options Outstanding, Exercise Price	$ 1.82
Options Exercisable, Number Exercisable (in Shares) | shares	37,475
Options Exercisable, Weighted Average Exercise Price	$ 1.82
Exercise Price Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	2.06
Exercise Price Range, Upper Range Limit	$ 2.40
Options Outstanding, Number (in Shares) | shares	73,000
Options Outstanding, Weighted Average Remaining Contractual Life	6 years 8 months 1 day
Options Outstanding, Exercise Price	$ 2.28
Options Exercisable, Number Exercisable (in Shares) | shares	70,778
Options Exercisable, Weighted Average Exercise Price	$ 2.29
Exercise Price Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	2.48
Exercise Price Range, Upper Range Limit	$ 2.48
Options Outstanding, Number (in Shares) | shares	7,333
Options Outstanding, Weighted Average Remaining Contractual Life	1 year 15 days
Options Outstanding, Exercise Price	$ 2.48
Options Exercisable, Number Exercisable (in Shares) | shares	7,333
Options Exercisable, Weighted Average Exercise Price	$ 2.48
Exercise Price Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	2.54
Exercise Price Range, Upper Range Limit	$ 2.54
Options Outstanding, Number (in Shares) | shares	113,333
Options Outstanding, Weighted Average Remaining Contractual Life	8 years 11 months 1 day
Options Outstanding, Exercise Price	$ 2.54
Options Exercisable, Number Exercisable (in Shares) | shares	37,778
Options Exercisable, Weighted Average Exercise Price	$ 2.54
Exercise Price Range 6 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	2.55
Exercise Price Range, Upper Range Limit	$ 3
Options Outstanding, Number (in Shares) | shares	80,667
Options Outstanding, Weighted Average Remaining Contractual Life	6 years 15 days
Options Outstanding, Exercise Price	$ 2.71
Options Exercisable, Number Exercisable (in Shares) | shares	80,667
Options Exercisable, Weighted Average Exercise Price	$ 2.71
Exercise Price Range 7 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	3.03
Exercise Price Range, Upper Range Limit	$ 3.30
Options Outstanding, Number (in Shares) | shares	45,600
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 3 months 26 days
Options Outstanding, Exercise Price	$ 3.08
Options Exercisable, Number Exercisable (in Shares) | shares	45,600
Options Exercisable, Weighted Average Exercise Price	$ 3.08
Exercise Price Range 8 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	3.45
Exercise Price Range, Upper Range Limit	$ 3.45
Options Outstanding, Number (in Shares) | shares	106,412
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 9 months 29 days
Options Outstanding, Exercise Price	$ 3.45
Options Exercisable, Number Exercisable (in Shares) | shares	106,412
Options Exercisable, Weighted Average Exercise Price	$ 3.45
Exercise Price Range 9 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	4.20
Exercise Price Range, Upper Range Limit	$ 44.20
Options Outstanding, Number (in Shares) | shares	80,000
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 8 months 9 days
Options Outstanding, Exercise Price	$ 4.20
Options Exercisable, Number Exercisable (in Shares) | shares	80,000
Options Exercisable, Weighted Average Exercise Price	$ 4.20
Exercise Price Range 10 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	5.70
Exercise Price Range, Upper Range Limit	$ 6.88
Options Outstanding, Number (in Shares) | shares	2,201
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 11 months 19 days
Options Outstanding, Exercise Price	$ 6.38
Options Exercisable, Number Exercisable (in Shares) | shares	1,816
Options Exercisable, Weighted Average Exercise Price	$ 6.32
Exercise Price Range 11 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	0.75
Exercise Price Range, Upper Range Limit	$ 6.68
Options Outstanding, Number (in Shares) | shares	705,990
Options Outstanding, Weighted Average Remaining Contractual Life	6 years 10 months 13 days
Options Outstanding, Exercise Price	$ 2.63
Options Exercisable, Number Exercisable (in Shares) | shares	526,648
Options Exercisable, Weighted Average Exercise Price	$ 2.81

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Status and Activity of Restricted Stock Awards (Details) - Restricted Stock [Member] - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Number of Shares Unreleased, Beginning Balance	287,666	262,562
Number of Shares Awarded	15,000	291,467
Number of Shares Released	(116,500)	(98,319)
Number of Shares Forfeited	(79,580)	(168,044)
Number of Shares Outstanding, Ending Balance	106,586	287,666
Weighted Average Grant Date Fair Value Beginning Balance	$ 2.70	$ 4.20
Weighted Average Grant Date Fair Value Awarded	2.35	2.46
Weighted Average Grant Date Fair Value Released	3.09	3.75
Weighted Average Grant Date Fair Value Forfeited	2.42	3.75
Weighted Average Grant Date Fair Value Ending Balance	$ 2.31	$ 2.70

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Note 10 - Income Taxes (Details) [Line Items]
Valuation allowance, deferred tax asset, increase (decrease), amount	$ (1,469,900)	$ (1,530,100)
Effective income tax rate reconciliation, at federal statutory income tax rate, percent	34.00%	34.00%
Percentage of meals and entertainment	50.00%
Internal Revenue Service (IRS) [Member] | Domestic Tax Authority [Member]
Note 10 - Income Taxes (Details) [Line Items]
Operating loss carryforwards	$ 61,000,000
Operating loss expiration date	expire in 2018
Internal Revenue Service (IRS) [Member] | Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]
Note 10 - Income Taxes (Details) [Line Items]
Tax credit carryforward, amount	$ 1,000,000
California Franchise Tax Board [Member] | State and Local Jurisdiction [Member]
Note 10 - Income Taxes (Details) [Line Items]
Operating loss carryforwards	$ 7,300,000
Operating loss expiration date	expire in 2014

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Components of Provision (Benefit) for Income Taxes [Abstract]
Federal
State
Foreign	$ 3,700	$ 3,100
Current income tax expens	$ 3,700	$ 3,100
Federal
State
Foreign
Deferred tax
Total	$ 3,700	$ 3,100

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of Differences Between Effective Income Tax Rate and Statutory Federal Tax Rate [Abstract]
Federal income tax (benefit) at statutory rate	$ (1,491,600)	$ (1,217,600)
State income tax (benefit) at statutory rate	(8,100)	(5,600)
Foreign tax rate differential	700	5,100
Compensation from exercise of non-qualified stock options and restricted stock awards	3,400	2,100
SBC – NQ cancellations	23,500	151,500
Change in valuation allowance	1,469,900	1,530,100
Warrant liability	(65,100)	(548,400)
Meals and entertainment (50%)	7,700	11,600
Tax rate changes	(2,500)	(1,000)
Other items	65,800	75,300
Provision (benefit) for income tax	$ 3,700	$ 3,100

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Deferred Income Taxes and Benefits [Abstract]
Net operating loss carryforwards	$ 21,032,900	$ 19,483,000
Tax credit carryforwards	1,047,300	1,047,000
Depreciation and amortization	(20,400)	55,000
Compensation expense – non-qualified stock options	729,500	588,000
Deferred revenue and maintenance service contracts	1,344,400	1,541,000
Warrant liability	800	7,000
Reserves and other	157,300	217,000
Total deferred tax assets	24,291,800	22,938,000
Deferred tax liability – capitalized software	(3,900)	(120,000)
Net deferred tax asset	24,287,900	22,818,000
Valuation allowance	$ (24,287,900)	(22,818,000)
Net deferred tax asset		$ 0

Concentration of Credit Risk (D

Concentration of Credit Risk (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Cash, Uninsured Amount	$ 1,559,900	$ 1,316,600

Concentration of Credit Risk -

Concentration of Credit Risk - Schedules of Concentration of Risk, by Risk Factor (Details) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	46.40%	25.60%
Sales Revenue, Net [Member] | Centric Systems [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	5.00%	4.30%
Sales Revenue, Net [Member] | Elosoft [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	10.90%	5.70%
Sales Revenue, Net [Member] | IDS LLC [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	5.80%	4.20%
Sales Revenue, Net [Member] | KitASP [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	3.80%	1.80%
Sales Revenue, Net [Member] | Raytheon [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	9.40%	1.10%
Sales Revenue, Net [Member] | Thermo Lab Systems [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	2.90%	4.40%
Sales Revenue, Net [Member] | Uniface [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	5.30%	2.00%
Sales Revenue, Net [Member] | Xerox [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	3.30%	2.10%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	63.00%	18.10%
Accounts Receivable [Member] | Centric Systems [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	13.20%	3.20%
Accounts Receivable [Member] | Elosoft [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	14.80%	6.90%
Accounts Receivable [Member] | IDS LLC [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	0.00%	0.40%
Accounts Receivable [Member] | KitASP [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	16.10%	0.00%
Accounts Receivable [Member] | Raytheon [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	1.60%	0.00%
Accounts Receivable [Member] | Thermo Lab Systems [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	7.80%	6.80%
Accounts Receivable [Member] | Uniface [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	1.90%	0.80%
Accounts Receivable [Member] | Xerox [Member]
Concentration Risk [Line Items]
Concentration of Credit Risk	7.60%	0.00%

Commitments and Contingencies68

Commitments and Contingencies (Details Narrative)	Feb. 01, 2014ft²	Aug. 21, 2013USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Rent expense			$ 396,400	$ 477,940
Mr.Eilam [Member]
Annual base salary		$ 275,000
Eligibllity for bonus			75,000
Minimum death benefit amount			$ 1,000,000
Campbell Facility [Member]
Lease square feet | ft²	10,659
Lease term	5 years
Lease expire date	2018-10

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)	Dec. 31, 2015USD ($)
Commitments And Contingencies - Schedule Of Future Minimum Lease Payments Details
2,016	$ 111,100
2,017	114,300
2,018	68,300
Total	$ 293,700

Employee 401(k) Plan (Details N

Employee 401(k) Plan (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 44,000	$ 60,200

Supplemental Disclosure of Ca71

Supplemental Disclosure of Cash Flow Information (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Warrants liability, period increase (decrease)	$ 615,700	$ 332,500
Fair value adjustment of warrants	(190,300)	(1,624,300)
Issuance cost	116,400
Cash disbursed	30,000
Prepaid expense and other assets noncurrent	40,700
Employee service share-based compensation, allocation of recognized period costs, capitalized amount	0	0
Deferred rent, long term	26,700	158,200
Deferred rent, current	21,000	44,500
Proceeds from issuance of warrants	(1,356,000)	1,356,000
Capital lease obligations		22,900
General and Administrative Expense [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Fair value adjustment of warrants	(18,100)	(64,200)
Accounts Payable and Accrued Liabilities [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Capitalized cost of property and equipment		61,000
Deferred Rent [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Capitalized cost of property and equipment		106,600
Deferred rent, long term		22,400
Deferred rent, current		84,200
Capitalized Software [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Capital lease obligations incurred	$ 182,400	24,900
Capitalized Software [Member] | Capitalized Computer Software Net [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Capital lease obligations incurred		16,500
Prepaid Expense [Member] | Capitalized Computer Software Net [Member]
Note 14 - Supplemental Disclosure of Cash Flow Information (Details) [Line Items]
Capital lease obligations incurred		$ 8,400

Supplemental Disclosure of Ca72

Supplemental Disclosure of Cash Flow Information - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($)		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Income Taxes	[1]	$ 4,400	$ 3,400
Interest
[1]	All such disbursements were for the payment of foreign income taxes.

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	Feb. 04, 2013	Dec. 31, 2015USD ($)Installmentsshares	Dec. 31, 2014USD ($)$ / sharesshares
Note 15 - Related Party Transactions (Details) [Line Items]
Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares			$ 3.90
Fair value adjustment of warrants | $		$ (190,300)	$ (1,624,300)
ip Capital Licensing Company ILLC [Member]
Note 15 - Related Party Transactions (Details) [Line Items]
Percentage of royalty fees and other consideration paid as fees	10.00%
Period of agreement	18 months
Number of days of written notice of termination	60 days
General and Administrative Expense [Member]
Note 15 - Related Party Transactions (Details) [Line Items]
Fair value adjustment of warrants | $		$ (18,100)	$ (64,200)
IP Capital Group Inc [Member]
Note 15 - Related Party Transactions (Details) [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares)			26,667
Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares			$ 3.90
Number of vesting installments | Installments		3
Number of warrants to vest (in shares)		13,333
Remaining warrants to vest (in shares)		13,333

Segment Information (Details Na

Segment Information (Details Narrative)	12 Months Ended
	Dec. 31, 2015Segment
Segment Reporting [Abstract]
Number of Reportable Segments	2

Segment Information - Schedule

Segment Information - Schedule of Revenue by Country (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue by Country	$ 4,981,000	$ 5,553,400
United States [Member]
Revenue by Country	2,267,600	2,501,800
Brazil [Member]
Revenue by Country	666,400	669,100
Other Countries [Member]
Revenue by Country	$ 2,047,000	$ 2,382,500

Subsequent Event (Details Narra

Subsequent Event (Details Narrative)	Jan. 27, 2016	Dec. 31, 2015
Reverse stock split		1-for-15
Subsequent Event [Member]
Reverse stock split	1-for-15